{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7e221be4",
   "metadata": {},
   "outputs": [],
   "source": [
    "!pip install sovai[full]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Clinical Trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sovai as sov\n",
    "\n",
    "sov.token_auth(token=\"visit https://sov.ai/profile for your token\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Prediction Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting data request for endpoint: clinical_trials\n",
      "Enabling full_history due to date range specification\n",
      "Prepared endpoint: /clinical_trials\n",
      "Full URL: https://data.sov.ai/clinical_trials with params: {'from_date': '2023-11-20T00:00:00', 'parquet': 'True', 'full_history': 'True'}\n",
      "Cache key: 52c649d3ac25ec41ec13485a3ce42e6f4eafb68f467b751a4e533143b033f7e1\n",
      "Purged cache entry\n",
      "Grabbing S3 Partitioned High client side\n",
      "Calling client-side handler with tickers=None, start_date=2023-11-20, end_date=None\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading data: 100%|██████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████| 498/498 [00:12<00:00, 39.84it/s]\n"
     ]
    }
   ],
   "source": [
    "df_apps = sov.data(\"clinical_trials\", start_date=\"2023-11-20\", verbose=True, purge_cache=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th>source</th>\n",
       "      <th>subsidiary</th>\n",
       "      <th>sponsor</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>sponsor_study_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>lead_sponsor</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>lead_sponsor_type</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>study_type</th>\n",
       "      <th>enrollment_count</th>\n",
       "      <th>number_of_locations</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>study_size_category</th>\n",
       "      <th>condition_keywords</th>\n",
       "      <th>primary_condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>primary_intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_arm_group_labels</th>\n",
       "      <th>intervention_description</th>\n",
       "      <th>has_data_monitoring_committee</th>\n",
       "      <th>responsible_party_investigator_affiliation</th>\n",
       "      <th>responsible_party_investigator_title</th>\n",
       "      <th>responsible_party_investigator_name</th>\n",
       "      <th>first_posted_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_completion_date</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>study_locations_city</th>\n",
       "      <th>study_locations_country</th>\n",
       "      <th>study_locations_geopoint</th>\n",
       "      <th>study_locations_facility</th>\n",
       "      <th>study_locations_zip</th>\n",
       "      <th>study_locations_state</th>\n",
       "      <th>standard_age_groups</th>\n",
       "      <th>sex</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>status_category</th>\n",
       "      <th>status_verified_date</th>\n",
       "      <th>primary_outcomes_measures</th>\n",
       "      <th>primary_outcomes_timeframes</th>\n",
       "      <th>primary_outcomes_descriptions</th>\n",
       "      <th>secondary_outcomes_measures</th>\n",
       "      <th>secondary_outcomes_timeframes</th>\n",
       "      <th>secondary_outcomes_descriptions</th>\n",
       "      <th>has_results</th>\n",
       "      <th>conditions</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>masking</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>study_duration_days</th>\n",
       "      <th>trial_duration</th>\n",
       "      <th>references_type</th>\n",
       "      <th>references_citation</th>\n",
       "      <th>references_pmid</th>\n",
       "      <th>collaborators_name</th>\n",
       "      <th>collaborators_class</th>\n",
       "      <th>ipd_sharing</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "      <th>class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8370</th>\n",
       "      <td>000100.KS</td>\n",
       "      <td>2024-01-19</td>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06247280</td>\n",
       "      <td>Multicenter Prospective And Retrospective Coho...</td>\n",
       "      <td>YMC048</td>\n",
       "      <td>Korean Registry Of Non-Small Cell Lung Cancer ...</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>2001</td>\n",
       "      <td>39</td>\n",
       "      <td>False</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>nan</td>\n",
       "      <td>Nsclc</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-02-07</td>\n",
       "      <td>2024-12-06</td>\n",
       "      <td>2022-06-24</td>\n",
       "      <td>NaT</td>\n",
       "      <td>2026-12-31</td>\n",
       "      <td>Chilgok; Wonju; Chuncheon; Bucheon-si; Uijeong...</td>\n",
       "      <td>Korea, Republic of; Korea, Republic of; Korea,...</td>\n",
       "      <td>lat: 35.99251, lon: 128.39785; lat: 37.35139, ...</td>\n",
       "      <td>Kyungpook National University Chilgok Hospital...</td>\n",
       "      <td>14584; 11765; 48108; 49267; 42415; 02841; 0331...</td>\n",
       "      <td>Daegu; Gangwon-do; Gangwon; Gyeonggi-do; Gyeon...</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>20</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>other</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Clinical characteristics of NSCLC patients wit...</td>\n",
       "      <td>12months, 18months, 24months, 36months; 12mont...</td>\n",
       "      <td>Analysis of clinical characteristics and clini...</td>\n",
       "      <td>Diagnosis Test Method; Diagnosis Test Method; ...</td>\n",
       "      <td>up to 36months; up to 36months; up to 36months...</td>\n",
       "      <td>Frequency of diagnostic test methods according...</td>\n",
       "      <td>False</td>\n",
       "      <td>Nsclc</td>\n",
       "      <td>Korean Registry Of Non-Small Cell Lung Cancer ...</td>\n",
       "      <td>The Korean Egfr Registry Is A Prospective Mult...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>The Korean Academy of Tuberculosis and Respira...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>UNDECIDED</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.500</td>\n",
       "      <td>896.000</td>\n",
       "      <td>0.693</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13697</th>\n",
       "      <td>000100.KS</td>\n",
       "      <td>2024-02-20</td>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06282549</td>\n",
       "      <td>A Prospective Long-Term Cohort Study To Identi...</td>\n",
       "      <td>YMC046</td>\n",
       "      <td>Study To Evaluate The Efficacy And Safety Of T...</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>1219</td>\n",
       "      <td>5</td>\n",
       "      <td>False</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Telmisartan/Amlodipine/Chlorthalidone Fixed-Do...</td>\n",
       "      <td>Essential Hypertension</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Telmisartan/Amlodipine/Chlorthalidone(Truset)</td>\n",
       "      <td>Telmisartan/Amlodipine/Chlorthalidone(Truset)</td>\n",
       "      <td>None</td>\n",
       "      <td>Telmisartan/Amlodipine/Chlorthalidone 40/5/12....</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-02-28</td>\n",
       "      <td>2024-11-19</td>\n",
       "      <td>2022-06-08</td>\n",
       "      <td>2027-03-31</td>\n",
       "      <td>2027-03-31</td>\n",
       "      <td>Busan; Daegu; Gwangju; Seoul; Seoul</td>\n",
       "      <td>Korea, Republic of; Korea, Republic of; Korea,...</td>\n",
       "      <td>lat: 35.10278, lon: 129.04028; lat: 35.87028, ...</td>\n",
       "      <td>Busan Veterans Hospital; Daegu Veterans Hospit...</td>\n",
       "      <td>46996; 42835; 62284; 05030; 05368</td>\n",
       "      <td>None</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>65</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>other</td>\n",
       "      <td>2024-11-01</td>\n",
       "      <td>Percentage of MACCE(Major Adverse Cardiovascul...</td>\n",
       "      <td>12, 24 and 36months</td>\n",
       "      <td>Percentage of MACCE(Major Adverse Cardiovascul...</td>\n",
       "      <td>Percentage of MACCE(Major Adverse Cardiovascul...</td>\n",
       "      <td>12, 24 and 36months; 12, 24 and 36months; 36mo...</td>\n",
       "      <td>Percentage of MACCE(Major Adverse Cardiovascul...</td>\n",
       "      <td>False</td>\n",
       "      <td>Essential Hypertension</td>\n",
       "      <td>This Study Is To Develop A Predictive Model Fo...</td>\n",
       "      <td>This Is A Phase Iv, Open-Label, Prospective, L...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>1757</td>\n",
       "      <td>1757.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.890</td>\n",
       "      <td>0.480</td>\n",
       "      <td>895.000</td>\n",
       "      <td>0.674</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14814</th>\n",
       "      <td>000100.KS</td>\n",
       "      <td>2024-02-28</td>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06293261</td>\n",
       "      <td>Multicenter, Prospective, Non-Interventional, ...</td>\n",
       "      <td>YMC043</td>\n",
       "      <td>Multicenter, Prospective, Non-Interventional, ...</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>5047</td>\n",
       "      <td>39</td>\n",
       "      <td>None</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>long-term efficacy and safety of Rusuampin Tab</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg</td>\n",
       "      <td>Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg</td>\n",
       "      <td>Rosuampin 10/10mg (Rosuvastatin; Rosuampin 10/...</td>\n",
       "      <td>Experimental Only, Not Included Active And Pla...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-03-05</td>\n",
       "      <td>2024-11-21</td>\n",
       "      <td>2020-06-27</td>\n",
       "      <td>2024-03-31</td>\n",
       "      <td>2024-03-31</td>\n",
       "      <td>Anyang-si; Busan; Changwon; Changwon; Chungbuk...</td>\n",
       "      <td>Korea, Republic of; Korea, Republic of; Korea,...</td>\n",
       "      <td>lat: 37.3925, lon: 126.92694; lat: 35.10278, l...</td>\n",
       "      <td>Hallym University Sacred Heart Hospital; Dong-...</td>\n",
       "      <td>49201; 06273</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>19</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-11-01</td>\n",
       "      <td>Occurence rate of MACCE(Major Adverse Cardiova...</td>\n",
       "      <td>Baseline, 12 Months</td>\n",
       "      <td>None</td>\n",
       "      <td>Change from baseline to 6/12 months in SBP and...</td>\n",
       "      <td>Baseline, 6, 12 Months; Baseline, 6, 12 Months...</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Hypertension; Hypercholesterolemia</td>\n",
       "      <td>This Study Is To Confirm The Long-Term Efficac...</td>\n",
       "      <td>All Treatments, Such As Drug Administration An...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>1373</td>\n",
       "      <td>1373.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.490</td>\n",
       "      <td>1373.000</td>\n",
       "      <td>0.691</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20491</th>\n",
       "      <td>000100.KS</td>\n",
       "      <td>2024-04-07</td>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06359626</td>\n",
       "      <td>An Open-Label, Randomized, Single-Dose, Oral A...</td>\n",
       "      <td>YHP2205-101</td>\n",
       "      <td>Bioequivalence Study Between Yhp2205 And Yhr24...</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>60</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>Pharmacokinetics; Bioequivalence</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>YHP2205</td>\n",
       "      <td>YHP2205; YHR2401</td>\n",
       "      <td>Sequence Group A; Sequence Group B; Sequence G...</td>\n",
       "      <td>Test Drug: Yhp2205; Comparator: Yhr2401</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-04-11</td>\n",
       "      <td>2024-11-12</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>Bumin Hospital</td>\n",
       "      <td>07590</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>19</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-11-01</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>0-36 hours; 0-36 hours</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>0-36 hours; 0-36 hours; 0-36 hours; 0-36 hours</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>False</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>A Randomized, Open-Label, Single-Dose, 2-Seque...</td>\n",
       "      <td>60 Healthy Subjects Will Be Randomized To One ...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>CROSSOVER</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.900</td>\n",
       "      <td>0.500</td>\n",
       "      <td>219.000</td>\n",
       "      <td>0.714</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34504</th>\n",
       "      <td>000100.KS</td>\n",
       "      <td>2024-07-14</td>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06517914</td>\n",
       "      <td>A First-In-Human, Phase 1, Randomized, Double-...</td>\n",
       "      <td>YH35995-101</td>\n",
       "      <td>A First-In-Human, Single- And Multiple-Ascendi...</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>96</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>YH35995; Gaucher Disease</td>\n",
       "      <td>Healthy Participants</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>YH35995</td>\n",
       "      <td>YH35995; Placebo</td>\n",
       "      <td>YH35995; Placebo</td>\n",
       "      <td>Oral Administration Of Yh35995; Oral Administr...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-07-24</td>\n",
       "      <td>2024-11-21</td>\n",
       "      <td>2024-07-29</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Seongnam</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.43861, lon: 127.13778</td>\n",
       "      <td>CHA Bundang Medical Center</td>\n",
       "      <td>13496</td>\n",
       "      <td>Bundang-gu</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>MALE</td>\n",
       "      <td>19</td>\n",
       "      <td>45</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-07-01</td>\n",
       "      <td>[Part A, B] Treatment-emergent adverse events ...</td>\n",
       "      <td>Part A: Day1-150, Part B: To be optimized base...</td>\n",
       "      <td>To assess the safety and tolerability of a sin...</td>\n",
       "      <td>[Part A] Maximum observed plasma concentration...</td>\n",
       "      <td>Day1-150; Day1-150; Day1-150; Day1-150; Day1-1...</td>\n",
       "      <td>To characterize the pharmacokinetics (PK) of Y...</td>\n",
       "      <td>False</td>\n",
       "      <td>Healthy Participants</td>\n",
       "      <td>This Is A Randomized, Double-Blind, First-In-H...</td>\n",
       "      <td>Yh35995 Is Being Developed As A Treatment For ...</td>\n",
       "      <td>DOUBLE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>YES</td>\n",
       "      <td>0.880</td>\n",
       "      <td>0.460</td>\n",
       "      <td>115.000</td>\n",
       "      <td>0.691</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11632</th>\n",
       "      <td>ZYDUSLIFE.NS</td>\n",
       "      <td>2024-02-08</td>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06398808</td>\n",
       "      <td>A Randomised, Double Blind, Parallel, Interven...</td>\n",
       "      <td>ZYIL1.23.001</td>\n",
       "      <td>A Study To Evaluate The Efficacy And Safety Of...</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>24</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Ulcerative Colitis</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>Arm1</td>\n",
       "      <td>Arm1; Arm 2</td>\n",
       "      <td>Arm 1 (ZYIL1 capsules &amp; placebo); Arm 2 (ZYIL1...</td>\n",
       "      <td>Zyil1 Capsules 25 Mg For Oral Administration +...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-05-03</td>\n",
       "      <td>2024-12-20</td>\n",
       "      <td>2024-04-08</td>\n",
       "      <td>2024-11-28</td>\n",
       "      <td>2024-11-22</td>\n",
       "      <td>Ahmedabad</td>\n",
       "      <td>India</td>\n",
       "      <td>lat: 23.02579, lon: 72.58727</td>\n",
       "      <td>ICON Hospital</td>\n",
       "      <td>380015</td>\n",
       "      <td>Gujarat</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>75</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>To assess the efficacy of ZYIL1 for induction ...</td>\n",
       "      <td>Baseline to week 6</td>\n",
       "      <td>clinical remission defined as an mMS score of ...</td>\n",
       "      <td>Proportion of participants achieving clinical ...</td>\n",
       "      <td>Week 6 and Week 12; Week 12; Week 6 and Week 1...</td>\n",
       "      <td>Clinical Response defined decrease from baseli...</td>\n",
       "      <td>False</td>\n",
       "      <td>Ulcerative Colitis</td>\n",
       "      <td>The Purpose Of This Study Is To Evaluate Effic...</td>\n",
       "      <td>This Is A Phase Iia, Randomized, Two Arms, Dou...</td>\n",
       "      <td>DOUBLE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>234</td>\n",
       "      <td>234.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.860</td>\n",
       "      <td>0.420</td>\n",
       "      <td>234.000</td>\n",
       "      <td>0.689</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25605</th>\n",
       "      <td>ZYDUSLIFE.NS</td>\n",
       "      <td>2024-05-09</td>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>NCT06427395</td>\n",
       "      <td>A Multicenter, Open-Label, Extension Clinical ...</td>\n",
       "      <td>SARO.23.002</td>\n",
       "      <td>Open-Label Extension Study Of Saroglitazar Mag...</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>150</td>\n",
       "      <td>41</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>Saroglitazar Magnesium; Primary Biliary Cholan...</td>\n",
       "      <td>Primary Biliary Cholangitis</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 Mg Will Be Assigned T...</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-05-23</td>\n",
       "      <td>2024-12-04</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Birmingham; Los Angeles; Pasadena; Sacramento;...</td>\n",
       "      <td>United States; United States; United States; U...</td>\n",
       "      <td>lat: 33.52066, lon: -86.80249; lat: 34.05223, ...</td>\n",
       "      <td>Zydus US007; Zydus US013; Zydus US011; Zydus U...</td>\n",
       "      <td>35294; 90048; 91105; 95817; 80045; 06520; 3222...</td>\n",
       "      <td>Alabama; California; California; California; C...</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-05-01</td>\n",
       "      <td>Number of participants with treatment-related ...</td>\n",
       "      <td>From baseline to 24 Months/EOT</td>\n",
       "      <td>None</td>\n",
       "      <td>Proportion of participants achieving biochemic...</td>\n",
       "      <td>From baseline to Months 12 and 24/EOT; From ba...</td>\n",
       "      <td>ALP \\&lt; 1.67 x ULN, ≥ 15% decrease in ALP, and ...</td>\n",
       "      <td>False</td>\n",
       "      <td>Primary Biliary Cholangitis</td>\n",
       "      <td>Open-Label Extension Study Of Saroglitazar Mag...</td>\n",
       "      <td>A Multicenter, Open-Label, Extension Clinical ...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.890</td>\n",
       "      <td>0.500</td>\n",
       "      <td>209.000</td>\n",
       "      <td>0.754</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56073</th>\n",
       "      <td>ZYDUSLIFE.NS</td>\n",
       "      <td>2024-12-20</td>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06757283</td>\n",
       "      <td>Evaluation Of Typhoid Conjugate Vaccine (Tcv) ...</td>\n",
       "      <td>PR-24059</td>\n",
       "      <td>Zyvac-Tcv Bangladesh Study</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>International Centre For Diarrhoeal Disease Re...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>4000</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Conjugate vaccine; Immunogenicity; Safety; Typ...</td>\n",
       "      <td>Typhoid Vaccination</td>\n",
       "      <td>BIOLOGICAL</td>\n",
       "      <td>Purified Vi capsular polysaccharide of Salmone...</td>\n",
       "      <td>Purified Vi capsular polysaccharide of Salmone...</td>\n",
       "      <td>Culture-negative control; Culture-positive case</td>\n",
       "      <td>Purified Vi Capsular Polysaccharide Of Salmone...</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-01-03</td>\n",
       "      <td>2025-01-03</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Dhaka</td>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>lat: 23.7104, lon: 90.40744</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>ALL</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Primary outcome</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Blood culture-confirmed typhoid fever</td>\n",
       "      <td>Secondary outcome; Secondary outcome</td>\n",
       "      <td>12 months; 12 months</td>\n",
       "      <td>Anti-Vi-IgG antibody concentration Blood cultu...</td>\n",
       "      <td>False</td>\n",
       "      <td>Typhoid Vaccination; Typhoid; Typhoid Fever</td>\n",
       "      <td>This Is A Prospective Closed Cohort, Open-Labe...</td>\n",
       "      <td>This Will Be A Phase Iii Effectiveness Study O...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.830</td>\n",
       "      <td>0.390</td>\n",
       "      <td>1053.000</td>\n",
       "      <td>0.669</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40602</th>\n",
       "      <td>ZYME</td>\n",
       "      <td>2024-07-22</td>\n",
       "      <td>listed</td>\n",
       "      <td>Zymeworks BC Inc</td>\n",
       "      <td>Zymeworks BC Inc.</td>\n",
       "      <td>NCT06523803</td>\n",
       "      <td>A Phase 1, Open-Label, Multicenter Study Of Zw...</td>\n",
       "      <td>ZWI-ZW171-101</td>\n",
       "      <td>A Study Of Zw171 In Participants With Advanced...</td>\n",
       "      <td>Zymeworks BC Inc.</td>\n",
       "      <td>Zymeworks Bc Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>160</td>\n",
       "      <td>5</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>Advanced or Metastatic Cancers; ADC; Antibody ...</td>\n",
       "      <td>Mesothelin-Expressing Advanced Cancers</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>ZW171</td>\n",
       "      <td>ZW171</td>\n",
       "      <td>ZW171</td>\n",
       "      <td>Administered Per Protocol Requirements</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-07-26</td>\n",
       "      <td>2024-12-06</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Los Angeles; Aurora; Louisville; Nashville; Ma...</td>\n",
       "      <td>United States; United States; United States; U...</td>\n",
       "      <td>lat: 34.05223, lon: -118.24368; lat: 39.72943,...</td>\n",
       "      <td>University of Southern California - Norris Com...</td>\n",
       "      <td>90089; 80045; 40202; 37203; M20 4BX</td>\n",
       "      <td>California; Colorado; Kentucky; Tennessee</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Incidence of dose-limiting toxicities (DLTs; P...</td>\n",
       "      <td>Up to 3 weeks; Up to approximately 2 years; Up...</td>\n",
       "      <td>Number of participants who experienced a DLT. ...</td>\n",
       "      <td>Confirmed objective response rate (Part 1); Du...</td>\n",
       "      <td>Up to approximately 2 years; Up to approximate...</td>\n",
       "      <td>Number of participants who achieved a best ove...</td>\n",
       "      <td>False</td>\n",
       "      <td>Mesothelin-Expressing Advanced Cancers</td>\n",
       "      <td>This Study Is Being Done To Find Out If Zw171 ...</td>\n",
       "      <td>Part 1 Of The Study Will Evaluate The Safety A...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.500</td>\n",
       "      <td>137.000</td>\n",
       "      <td>0.728</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38586</th>\n",
       "      <td>ZYME</td>\n",
       "      <td>2024-08-13</td>\n",
       "      <td>listed</td>\n",
       "      <td>Zymeworks BC Inc</td>\n",
       "      <td>Zymeworks BC Inc.</td>\n",
       "      <td>NCT06555744</td>\n",
       "      <td>A Phase 1, Open-Label, Multicenter Study To As...</td>\n",
       "      <td>ZWI-ZW191-101</td>\n",
       "      <td>A Study Of Zw191 In Participants With Solid Tu...</td>\n",
       "      <td>Zymeworks BC Inc.</td>\n",
       "      <td>Zymeworks Bc Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>145</td>\n",
       "      <td>6</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>Advanced or Metastatic Cancers; ADC; Folate al...</td>\n",
       "      <td>Advanced Solid Tumors</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>ZW191</td>\n",
       "      <td>ZW191</td>\n",
       "      <td>ZW191</td>\n",
       "      <td>Administered Intravenously</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-08-15</td>\n",
       "      <td>2024-12-06</td>\n",
       "      <td>NaT</td>\n",
       "      <td>2027-01-01</td>\n",
       "      <td>2026-12-01</td>\n",
       "      <td>San Antonio; Fairfax; Nedlands; Saitama; Tokyo...</td>\n",
       "      <td>United States; United States; Australia; Japan...</td>\n",
       "      <td>lat: 29.42412, lon: -98.49363; lat: 38.84622, ...</td>\n",
       "      <td>NEXT Oncology; NEXT Virginia; Linear Clinical ...</td>\n",
       "      <td>78229; 22031; WA 6009; 350-1298; 104-0045; 168583</td>\n",
       "      <td>Texas; Virginia</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Incidence of dose-limiting toxicities (DLTs; P...</td>\n",
       "      <td>Up to 3 weeks; Up to approximately 2 years; Up...</td>\n",
       "      <td>Number of participants who experienced a DLT. ...</td>\n",
       "      <td>Confirmed objective response rate (Part 1); Cl...</td>\n",
       "      <td>Up to approximately 2 years; Up to approximate...</td>\n",
       "      <td>Number of participants who achieved a best ove...</td>\n",
       "      <td>False</td>\n",
       "      <td>Advanced Solid Tumors</td>\n",
       "      <td>The Purpose Of This Study Is To Find Out If Zw...</td>\n",
       "      <td>Part 1 Of The Study Will Evaluate The Safety A...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.500</td>\n",
       "      <td>115.000</td>\n",
       "      <td>0.728</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>57731 rows × 77 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             ticker       date   source                  subsidiary  \\\n",
       "8370      000100.KS 2024-01-19  foreign           Yuhan Corporation   \n",
       "13697     000100.KS 2024-02-20  foreign           Yuhan Corporation   \n",
       "14814     000100.KS 2024-02-28  foreign           Yuhan Corporation   \n",
       "20491     000100.KS 2024-04-07  foreign           Yuhan Corporation   \n",
       "34504     000100.KS 2024-07-14  foreign           Yuhan Corporation   \n",
       "...             ...        ...      ...                         ...   \n",
       "11632  ZYDUSLIFE.NS 2024-02-08  foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "25605  ZYDUSLIFE.NS 2024-05-09  foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "56073  ZYDUSLIFE.NS 2024-12-20  foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "40602          ZYME 2024-07-22   listed            Zymeworks BC Inc   \n",
       "38586          ZYME 2024-08-13   listed            Zymeworks BC Inc   \n",
       "\n",
       "                          sponsor     trial_id  \\\n",
       "8370            Yuhan Corporation  NCT06247280   \n",
       "13697           Yuhan Corporation  NCT06282549   \n",
       "14814           Yuhan Corporation  NCT06293261   \n",
       "20491           Yuhan Corporation  NCT06359626   \n",
       "34504           Yuhan Corporation  NCT06517914   \n",
       "...                           ...          ...   \n",
       "11632  Zydus Lifesciences Limited  NCT06398808   \n",
       "25605     Zydus Therapeutics Inc.  NCT06427395   \n",
       "56073  Zydus Lifesciences Limited  NCT06757283   \n",
       "40602           Zymeworks BC Inc.  NCT06523803   \n",
       "38586           Zymeworks BC Inc.  NCT06555744   \n",
       "\n",
       "                                          official_title sponsor_study_id  \\\n",
       "8370   Multicenter Prospective And Retrospective Coho...           YMC048   \n",
       "13697  A Prospective Long-Term Cohort Study To Identi...           YMC046   \n",
       "14814  Multicenter, Prospective, Non-Interventional, ...           YMC043   \n",
       "20491  An Open-Label, Randomized, Single-Dose, Oral A...      YHP2205-101   \n",
       "34504  A First-In-Human, Phase 1, Randomized, Double-...      YH35995-101   \n",
       "...                                                  ...              ...   \n",
       "11632  A Randomised, Double Blind, Parallel, Interven...     ZYIL1.23.001   \n",
       "25605  A Multicenter, Open-Label, Extension Clinical ...      SARO.23.002   \n",
       "56073  Evaluation Of Typhoid Conjugate Vaccine (Tcv) ...         PR-24059   \n",
       "40602  A Phase 1, Open-Label, Multicenter Study Of Zw...    ZWI-ZW171-101   \n",
       "38586  A Phase 1, Open-Label, Multicenter Study To As...    ZWI-ZW191-101   \n",
       "\n",
       "                                             brief_title  \\\n",
       "8370   Korean Registry Of Non-Small Cell Lung Cancer ...   \n",
       "13697  Study To Evaluate The Efficacy And Safety Of T...   \n",
       "14814  Multicenter, Prospective, Non-Interventional, ...   \n",
       "20491  Bioequivalence Study Between Yhp2205 And Yhr24...   \n",
       "34504  A First-In-Human, Single- And Multiple-Ascendi...   \n",
       "...                                                  ...   \n",
       "11632  A Study To Evaluate The Efficacy And Safety Of...   \n",
       "25605  Open-Label Extension Study Of Saroglitazar Mag...   \n",
       "56073                         Zyvac-Tcv Bangladesh Study   \n",
       "40602  A Study Of Zw171 In Participants With Advanced...   \n",
       "38586  A Study Of Zw191 In Participants With Solid Tu...   \n",
       "\n",
       "                                            lead_sponsor  \\\n",
       "8370                                   Yuhan Corporation   \n",
       "13697                                  Yuhan Corporation   \n",
       "14814                                  Yuhan Corporation   \n",
       "20491                                  Yuhan Corporation   \n",
       "34504                                  Yuhan Corporation   \n",
       "...                                                  ...   \n",
       "11632                         Zydus Lifesciences Limited   \n",
       "25605                            Zydus Therapeutics Inc.   \n",
       "56073  International Centre for Diarrhoeal Disease Re...   \n",
       "40602                                  Zymeworks BC Inc.   \n",
       "38586                                  Zymeworks BC Inc.   \n",
       "\n",
       "                                       lead_sponsor_name sponsor_type  \\\n",
       "8370                                   Yuhan Corporation     INDUSTRY   \n",
       "13697                                  Yuhan Corporation     INDUSTRY   \n",
       "14814                                  Yuhan Corporation     INDUSTRY   \n",
       "20491                                  Yuhan Corporation     INDUSTRY   \n",
       "34504                                  Yuhan Corporation     INDUSTRY   \n",
       "...                                                  ...          ...   \n",
       "11632                         Zydus Lifesciences Limited     INDUSTRY   \n",
       "25605                            Zydus Therapeutics Inc.     INDUSTRY   \n",
       "56073  International Centre For Diarrhoeal Disease Re...        OTHER   \n",
       "40602                                  Zymeworks Bc Inc.     INDUSTRY   \n",
       "38586                                  Zymeworks Bc Inc.     INDUSTRY   \n",
       "\n",
       "      lead_sponsor_type phase_category      study_type  enrollment_count  \\\n",
       "8370           INDUSTRY  not_specified   OBSERVATIONAL              2001   \n",
       "13697          INDUSTRY  not_specified   OBSERVATIONAL              1219   \n",
       "14814          INDUSTRY  not_specified   OBSERVATIONAL              5047   \n",
       "20491          INDUSTRY        phase_1  INTERVENTIONAL                60   \n",
       "34504          INDUSTRY        phase_1  INTERVENTIONAL                96   \n",
       "...                 ...            ...             ...               ...   \n",
       "11632          INDUSTRY        phase_2  INTERVENTIONAL                24   \n",
       "25605          INDUSTRY        phase_3  INTERVENTIONAL               150   \n",
       "56073             OTHER        phase_3  INTERVENTIONAL              4000   \n",
       "40602          INDUSTRY        phase_1  INTERVENTIONAL               160   \n",
       "38586          INDUSTRY        phase_1  INTERVENTIONAL               145   \n",
       "\n",
       "       number_of_locations healthy_volunteers enrollment_type  \\\n",
       "8370                    39              False          ACTUAL   \n",
       "13697                    5              False          ACTUAL   \n",
       "14814                   39               None          ACTUAL   \n",
       "20491                    1               True          ACTUAL   \n",
       "34504                    1               True       ESTIMATED   \n",
       "...                    ...                ...             ...   \n",
       "11632                    1              False          ACTUAL   \n",
       "25605                   41              False       ESTIMATED   \n",
       "56073                    1               True       ESTIMATED   \n",
       "40602                    5              False       ESTIMATED   \n",
       "38586                    6              False       ESTIMATED   \n",
       "\n",
       "      study_size_category                                 condition_keywords  \\\n",
       "8370           Very Large                                                nan   \n",
       "13697          Very Large  Telmisartan/Amlodipine/Chlorthalidone Fixed-Do...   \n",
       "14814          Very Large     long-term efficacy and safety of Rusuampin Tab   \n",
       "20491               Small                   Pharmacokinetics; Bioequivalence   \n",
       "34504               Small                           YH35995; Gaucher Disease   \n",
       "...                   ...                                                ...   \n",
       "11632               Small                                                nan   \n",
       "25605              Medium  Saroglitazar Magnesium; Primary Biliary Cholan...   \n",
       "56073          Very Large  Conjugate vaccine; Immunogenicity; Safety; Typ...   \n",
       "40602              Medium  Advanced or Metastatic Cancers; ADC; Antibody ...   \n",
       "38586              Medium  Advanced or Metastatic Cancers; ADC; Folate al...   \n",
       "\n",
       "                            primary_condition intervention_type  \\\n",
       "8370                                    Nsclc               nan   \n",
       "13697                  Essential Hypertension              DRUG   \n",
       "14814                            Hypertension              DRUG   \n",
       "20491                      Healthy Volunteers        DRUG; DRUG   \n",
       "34504                    Healthy Participants        DRUG; DRUG   \n",
       "...                                       ...               ...   \n",
       "11632                      Ulcerative Colitis        DRUG; DRUG   \n",
       "25605             Primary Biliary Cholangitis              DRUG   \n",
       "56073                     Typhoid Vaccination        BIOLOGICAL   \n",
       "40602  Mesothelin-Expressing Advanced Cancers              DRUG   \n",
       "38586                   Advanced Solid Tumors              DRUG   \n",
       "\n",
       "                                    primary_intervention  \\\n",
       "8370                                                 nan   \n",
       "13697      Telmisartan/Amlodipine/Chlorthalidone(Truset)   \n",
       "14814           Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg   \n",
       "20491                                            YHP2205   \n",
       "34504                                            YH35995   \n",
       "...                                                  ...   \n",
       "11632                                               Arm1   \n",
       "25605                        Saroglitazar Magnesium 1 mg   \n",
       "56073  Purified Vi capsular polysaccharide of Salmone...   \n",
       "40602                                              ZW171   \n",
       "38586                                              ZW191   \n",
       "\n",
       "                                       intervention_name  \\\n",
       "8370                                                 nan   \n",
       "13697      Telmisartan/Amlodipine/Chlorthalidone(Truset)   \n",
       "14814           Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg   \n",
       "20491                                   YHP2205; YHR2401   \n",
       "34504                                   YH35995; Placebo   \n",
       "...                                                  ...   \n",
       "11632                                        Arm1; Arm 2   \n",
       "25605                        Saroglitazar Magnesium 1 mg   \n",
       "56073  Purified Vi capsular polysaccharide of Salmone...   \n",
       "40602                                              ZW171   \n",
       "38586                                              ZW191   \n",
       "\n",
       "                           intervention_arm_group_labels  \\\n",
       "8370                                                None   \n",
       "13697                                               None   \n",
       "14814  Rosuampin 10/10mg (Rosuvastatin; Rosuampin 10/...   \n",
       "20491  Sequence Group A; Sequence Group B; Sequence G...   \n",
       "34504                                   YH35995; Placebo   \n",
       "...                                                  ...   \n",
       "11632  Arm 1 (ZYIL1 capsules & placebo); Arm 2 (ZYIL1...   \n",
       "25605                        Saroglitazar Magnesium 1 mg   \n",
       "56073    Culture-negative control; Culture-positive case   \n",
       "40602                                              ZW171   \n",
       "38586                                              ZW191   \n",
       "\n",
       "                                intervention_description  \\\n",
       "8370                                                None   \n",
       "13697  Telmisartan/Amlodipine/Chlorthalidone 40/5/12....   \n",
       "14814  Experimental Only, Not Included Active And Pla...   \n",
       "20491            Test Drug: Yhp2205; Comparator: Yhr2401   \n",
       "34504  Oral Administration Of Yh35995; Oral Administr...   \n",
       "...                                                  ...   \n",
       "11632  Zyil1 Capsules 25 Mg For Oral Administration +...   \n",
       "25605  Saroglitazar Magnesium 1 Mg Will Be Assigned T...   \n",
       "56073  Purified Vi Capsular Polysaccharide Of Salmone...   \n",
       "40602             Administered Per Protocol Requirements   \n",
       "38586                         Administered Intravenously   \n",
       "\n",
       "      has_data_monitoring_committee  \\\n",
       "8370                          False   \n",
       "13697                         False   \n",
       "14814                         False   \n",
       "20491                         False   \n",
       "34504                         False   \n",
       "...                             ...   \n",
       "11632                         False   \n",
       "25605                          True   \n",
       "56073                          True   \n",
       "40602                         False   \n",
       "38586                         False   \n",
       "\n",
       "      responsible_party_investigator_affiliation  \\\n",
       "8370                                        None   \n",
       "13697                                       None   \n",
       "14814                                       None   \n",
       "20491                                       None   \n",
       "34504                                       None   \n",
       "...                                          ...   \n",
       "11632                                       None   \n",
       "25605                                       None   \n",
       "56073                                       None   \n",
       "40602                                       None   \n",
       "38586                                       None   \n",
       "\n",
       "      responsible_party_investigator_title  \\\n",
       "8370                                  None   \n",
       "13697                                 None   \n",
       "14814                                 None   \n",
       "20491                                 None   \n",
       "34504                                 None   \n",
       "...                                    ...   \n",
       "11632                                 None   \n",
       "25605                                 None   \n",
       "56073                                 None   \n",
       "40602                                 None   \n",
       "38586                                 None   \n",
       "\n",
       "      responsible_party_investigator_name first_posted_date  \\\n",
       "8370                                 None        2024-02-07   \n",
       "13697                                None        2024-02-28   \n",
       "14814                                None        2024-03-05   \n",
       "20491                                None        2024-04-11   \n",
       "34504                                None        2024-07-24   \n",
       "...                                   ...               ...   \n",
       "11632                                None        2024-05-03   \n",
       "25605                                None        2024-05-23   \n",
       "56073                                None        2025-01-03   \n",
       "40602                                None        2024-07-26   \n",
       "38586                                None        2024-08-15   \n",
       "\n",
       "      last_update_posted_date start_date study_completion_date  \\\n",
       "8370               2024-12-06 2022-06-24                   NaT   \n",
       "13697              2024-11-19 2022-06-08            2027-03-31   \n",
       "14814              2024-11-21 2020-06-27            2024-03-31   \n",
       "20491              2024-11-12        NaT                   NaT   \n",
       "34504              2024-11-21 2024-07-29                   NaT   \n",
       "...                       ...        ...                   ...   \n",
       "11632              2024-12-20 2024-04-08            2024-11-28   \n",
       "25605              2024-12-04        NaT                   NaT   \n",
       "56073              2025-01-03        NaT                   NaT   \n",
       "40602              2024-12-06        NaT                   NaT   \n",
       "38586              2024-12-06        NaT            2027-01-01   \n",
       "\n",
       "      primary_completion_date  \\\n",
       "8370               2026-12-31   \n",
       "13697              2027-03-31   \n",
       "14814              2024-03-31   \n",
       "20491                     NaT   \n",
       "34504                     NaT   \n",
       "...                       ...   \n",
       "11632              2024-11-22   \n",
       "25605                     NaT   \n",
       "56073                     NaT   \n",
       "40602                     NaT   \n",
       "38586              2026-12-01   \n",
       "\n",
       "                                    study_locations_city  \\\n",
       "8370   Chilgok; Wonju; Chuncheon; Bucheon-si; Uijeong...   \n",
       "13697                Busan; Daegu; Gwangju; Seoul; Seoul   \n",
       "14814  Anyang-si; Busan; Changwon; Changwon; Chungbuk...   \n",
       "20491                                              Seoul   \n",
       "34504                                           Seongnam   \n",
       "...                                                  ...   \n",
       "11632                                          Ahmedabad   \n",
       "25605  Birmingham; Los Angeles; Pasadena; Sacramento;...   \n",
       "56073                                              Dhaka   \n",
       "40602  Los Angeles; Aurora; Louisville; Nashville; Ma...   \n",
       "38586  San Antonio; Fairfax; Nedlands; Saitama; Tokyo...   \n",
       "\n",
       "                                 study_locations_country  \\\n",
       "8370   Korea, Republic of; Korea, Republic of; Korea,...   \n",
       "13697  Korea, Republic of; Korea, Republic of; Korea,...   \n",
       "14814  Korea, Republic of; Korea, Republic of; Korea,...   \n",
       "20491                                 Korea, Republic of   \n",
       "34504                                 Korea, Republic of   \n",
       "...                                                  ...   \n",
       "11632                                              India   \n",
       "25605  United States; United States; United States; U...   \n",
       "56073                                         Bangladesh   \n",
       "40602  United States; United States; United States; U...   \n",
       "38586  United States; United States; Australia; Japan...   \n",
       "\n",
       "                                study_locations_geopoint  \\\n",
       "8370   lat: 35.99251, lon: 128.39785; lat: 37.35139, ...   \n",
       "13697  lat: 35.10278, lon: 129.04028; lat: 35.87028, ...   \n",
       "14814  lat: 37.3925, lon: 126.92694; lat: 35.10278, l...   \n",
       "20491                         lat: 37.566, lon: 126.9784   \n",
       "34504                      lat: 37.43861, lon: 127.13778   \n",
       "...                                                  ...   \n",
       "11632                       lat: 23.02579, lon: 72.58727   \n",
       "25605  lat: 33.52066, lon: -86.80249; lat: 34.05223, ...   \n",
       "56073                        lat: 23.7104, lon: 90.40744   \n",
       "40602  lat: 34.05223, lon: -118.24368; lat: 39.72943,...   \n",
       "38586  lat: 29.42412, lon: -98.49363; lat: 38.84622, ...   \n",
       "\n",
       "                                study_locations_facility  \\\n",
       "8370   Kyungpook National University Chilgok Hospital...   \n",
       "13697  Busan Veterans Hospital; Daegu Veterans Hospit...   \n",
       "14814  Hallym University Sacred Heart Hospital; Dong-...   \n",
       "20491                                     Bumin Hospital   \n",
       "34504                         CHA Bundang Medical Center   \n",
       "...                                                  ...   \n",
       "11632                                      ICON Hospital   \n",
       "25605  Zydus US007; Zydus US013; Zydus US011; Zydus U...   \n",
       "56073  International Centre for Diarrhoeal Disease Re...   \n",
       "40602  University of Southern California - Norris Com...   \n",
       "38586  NEXT Oncology; NEXT Virginia; Linear Clinical ...   \n",
       "\n",
       "                                     study_locations_zip  \\\n",
       "8370   14584; 11765; 48108; 49267; 42415; 02841; 0331...   \n",
       "13697                  46996; 42835; 62284; 05030; 05368   \n",
       "14814                                       49201; 06273   \n",
       "20491                                              07590   \n",
       "34504                                              13496   \n",
       "...                                                  ...   \n",
       "11632                                             380015   \n",
       "25605  35294; 90048; 91105; 95817; 80045; 06520; 3222...   \n",
       "56073                                               None   \n",
       "40602                90089; 80045; 40202; 37203; M20 4BX   \n",
       "38586  78229; 22031; WA 6009; 350-1298; 104-0045; 168583   \n",
       "\n",
       "                                   study_locations_state standard_age_groups  \\\n",
       "8370   Daegu; Gangwon-do; Gangwon; Gyeonggi-do; Gyeon...  ADULT; OLDER_ADULT   \n",
       "13697                                               None         OLDER_ADULT   \n",
       "14814                                               None  ADULT; OLDER_ADULT   \n",
       "20491                                               None  ADULT; OLDER_ADULT   \n",
       "34504                                         Bundang-gu               ADULT   \n",
       "...                                                  ...                 ...   \n",
       "11632                                            Gujarat  ADULT; OLDER_ADULT   \n",
       "25605  Alabama; California; California; California; C...  ADULT; OLDER_ADULT   \n",
       "56073                                               None               CHILD   \n",
       "40602          California; Colorado; Kentucky; Tennessee  ADULT; OLDER_ADULT   \n",
       "38586                                    Texas; Virginia  ADULT; OLDER_ADULT   \n",
       "\n",
       "        sex  minimum_age  maximum_age         overall_status status_category  \\\n",
       "8370    ALL           20         <NA>  ACTIVE_NOT_RECRUITING           other   \n",
       "13697   ALL           65         <NA>  ACTIVE_NOT_RECRUITING           other   \n",
       "14814   ALL           19         <NA>              COMPLETED       completed   \n",
       "20491   ALL           19         <NA>              COMPLETED       completed   \n",
       "34504  MALE           19           45             RECRUITING          active   \n",
       "...     ...          ...          ...                    ...             ...   \n",
       "11632   ALL           18           75              COMPLETED       completed   \n",
       "25605   ALL           18         <NA>             RECRUITING          active   \n",
       "56073   ALL            0           15     NOT_YET_RECRUITING          active   \n",
       "40602   ALL           18         <NA>             RECRUITING          active   \n",
       "38586   ALL           18         <NA>             RECRUITING          active   \n",
       "\n",
       "      status_verified_date                          primary_outcomes_measures  \\\n",
       "8370            2024-12-01  Clinical characteristics of NSCLC patients wit...   \n",
       "13697           2024-11-01  Percentage of MACCE(Major Adverse Cardiovascul...   \n",
       "14814           2024-11-01  Occurence rate of MACCE(Major Adverse Cardiova...   \n",
       "20491           2024-11-01  Area under the plasma drug concentration-time ...   \n",
       "34504           2024-07-01  [Part A, B] Treatment-emergent adverse events ...   \n",
       "...                    ...                                                ...   \n",
       "11632           2024-12-01  To assess the efficacy of ZYIL1 for induction ...   \n",
       "25605           2024-05-01  Number of participants with treatment-related ...   \n",
       "56073           2024-12-01                                    Primary outcome   \n",
       "40602           2024-12-01  Incidence of dose-limiting toxicities (DLTs; P...   \n",
       "38586           2024-12-01  Incidence of dose-limiting toxicities (DLTs; P...   \n",
       "\n",
       "                             primary_outcomes_timeframes  \\\n",
       "8370   12months, 18months, 24months, 36months; 12mont...   \n",
       "13697                                12, 24 and 36months   \n",
       "14814                                Baseline, 12 Months   \n",
       "20491                             0-36 hours; 0-36 hours   \n",
       "34504  Part A: Day1-150, Part B: To be optimized base...   \n",
       "...                                                  ...   \n",
       "11632                                 Baseline to week 6   \n",
       "25605                     From baseline to 24 Months/EOT   \n",
       "56073                                          12 months   \n",
       "40602  Up to 3 weeks; Up to approximately 2 years; Up...   \n",
       "38586  Up to 3 weeks; Up to approximately 2 years; Up...   \n",
       "\n",
       "                           primary_outcomes_descriptions  \\\n",
       "8370   Analysis of clinical characteristics and clini...   \n",
       "13697  Percentage of MACCE(Major Adverse Cardiovascul...   \n",
       "14814                                               None   \n",
       "20491  Area under the plasma drug concentration-time ...   \n",
       "34504  To assess the safety and tolerability of a sin...   \n",
       "...                                                  ...   \n",
       "11632  clinical remission defined as an mMS score of ...   \n",
       "25605                                               None   \n",
       "56073              Blood culture-confirmed typhoid fever   \n",
       "40602  Number of participants who experienced a DLT. ...   \n",
       "38586  Number of participants who experienced a DLT. ...   \n",
       "\n",
       "                             secondary_outcomes_measures  \\\n",
       "8370   Diagnosis Test Method; Diagnosis Test Method; ...   \n",
       "13697  Percentage of MACCE(Major Adverse Cardiovascul...   \n",
       "14814  Change from baseline to 6/12 months in SBP and...   \n",
       "20491  Area under the plasma drug concentration-time ...   \n",
       "34504  [Part A] Maximum observed plasma concentration...   \n",
       "...                                                  ...   \n",
       "11632  Proportion of participants achieving clinical ...   \n",
       "25605  Proportion of participants achieving biochemic...   \n",
       "56073               Secondary outcome; Secondary outcome   \n",
       "40602  Confirmed objective response rate (Part 1); Du...   \n",
       "38586  Confirmed objective response rate (Part 1); Cl...   \n",
       "\n",
       "                           secondary_outcomes_timeframes  \\\n",
       "8370   up to 36months; up to 36months; up to 36months...   \n",
       "13697  12, 24 and 36months; 12, 24 and 36months; 36mo...   \n",
       "14814  Baseline, 6, 12 Months; Baseline, 6, 12 Months...   \n",
       "20491     0-36 hours; 0-36 hours; 0-36 hours; 0-36 hours   \n",
       "34504  Day1-150; Day1-150; Day1-150; Day1-150; Day1-1...   \n",
       "...                                                  ...   \n",
       "11632  Week 6 and Week 12; Week 12; Week 6 and Week 1...   \n",
       "25605  From baseline to Months 12 and 24/EOT; From ba...   \n",
       "56073                               12 months; 12 months   \n",
       "40602  Up to approximately 2 years; Up to approximate...   \n",
       "38586  Up to approximately 2 years; Up to approximate...   \n",
       "\n",
       "                         secondary_outcomes_descriptions  has_results  \\\n",
       "8370   Frequency of diagnostic test methods according...        False   \n",
       "13697  Percentage of MACCE(Major Adverse Cardiovascul...        False   \n",
       "14814                                               None        False   \n",
       "20491  Area under the plasma drug concentration-time ...        False   \n",
       "34504  To characterize the pharmacokinetics (PK) of Y...        False   \n",
       "...                                                  ...          ...   \n",
       "11632  Clinical Response defined decrease from baseli...        False   \n",
       "25605  ALP \\< 1.67 x ULN, ≥ 15% decrease in ALP, and ...        False   \n",
       "56073  Anti-Vi-IgG antibody concentration Blood cultu...        False   \n",
       "40602  Number of participants who achieved a best ove...        False   \n",
       "38586  Number of participants who achieved a best ove...        False   \n",
       "\n",
       "                                        conditions  \\\n",
       "8370                                         Nsclc   \n",
       "13697                       Essential Hypertension   \n",
       "14814           Hypertension; Hypercholesterolemia   \n",
       "20491                           Healthy Volunteers   \n",
       "34504                         Healthy Participants   \n",
       "...                                            ...   \n",
       "11632                           Ulcerative Colitis   \n",
       "25605                  Primary Biliary Cholangitis   \n",
       "56073  Typhoid Vaccination; Typhoid; Typhoid Fever   \n",
       "40602       Mesothelin-Expressing Advanced Cancers   \n",
       "38586                        Advanced Solid Tumors   \n",
       "\n",
       "                                           brief_summary  \\\n",
       "8370   Korean Registry Of Non-Small Cell Lung Cancer ...   \n",
       "13697  This Study Is To Develop A Predictive Model Fo...   \n",
       "14814  This Study Is To Confirm The Long-Term Efficac...   \n",
       "20491  A Randomized, Open-Label, Single-Dose, 2-Seque...   \n",
       "34504  This Is A Randomized, Double-Blind, First-In-H...   \n",
       "...                                                  ...   \n",
       "11632  The Purpose Of This Study Is To Evaluate Effic...   \n",
       "25605  Open-Label Extension Study Of Saroglitazar Mag...   \n",
       "56073  This Is A Prospective Closed Cohort, Open-Labe...   \n",
       "40602  This Study Is Being Done To Find Out If Zw171 ...   \n",
       "38586  The Purpose Of This Study Is To Find Out If Zw...   \n",
       "\n",
       "                                    detailed_description masking  \\\n",
       "8370   The Korean Egfr Registry Is A Prospective Mult...    None   \n",
       "13697  This Is A Phase Iv, Open-Label, Prospective, L...    None   \n",
       "14814  All Treatments, Such As Drug Administration An...    None   \n",
       "20491  60 Healthy Subjects Will Be Randomized To One ...    NONE   \n",
       "34504  Yh35995 Is Being Developed As A Treatment For ...  DOUBLE   \n",
       "...                                                  ...     ...   \n",
       "11632  This Is A Phase Iia, Randomized, Two Arms, Dou...  DOUBLE   \n",
       "25605  A Multicenter, Open-Label, Extension Clinical ...    NONE   \n",
       "56073  This Will Be A Phase Iii Effectiveness Study O...    NONE   \n",
       "40602  Part 1 Of The Study Will Evaluate The Safety A...    NONE   \n",
       "38586  Part 1 Of The Study Will Evaluate The Safety A...    NONE   \n",
       "\n",
       "           allocation intervention_model primary_purpose  has_expanded_access  \\\n",
       "8370             None               None            None                False   \n",
       "13697            None               None            None                False   \n",
       "14814            None               None            None                False   \n",
       "20491      RANDOMIZED          CROSSOVER       TREATMENT                False   \n",
       "34504      RANDOMIZED           PARALLEL       TREATMENT                False   \n",
       "...               ...                ...             ...                  ...   \n",
       "11632      RANDOMIZED           PARALLEL       TREATMENT                False   \n",
       "25605              NA       SINGLE_GROUP       TREATMENT                False   \n",
       "56073  NON_RANDOMIZED       SINGLE_GROUP      PREVENTION                False   \n",
       "40602              NA       SINGLE_GROUP       TREATMENT                False   \n",
       "38586              NA       SINGLE_GROUP       TREATMENT                False   \n",
       "\n",
       "       study_duration_days  trial_duration references_type  \\\n",
       "8370                  <NA>             NaN            None   \n",
       "13697                 1757        1757.000            None   \n",
       "14814                 1373        1373.000            None   \n",
       "20491                 <NA>             NaN            None   \n",
       "34504                 <NA>             NaN            None   \n",
       "...                    ...             ...             ...   \n",
       "11632                  234         234.000            None   \n",
       "25605                 <NA>             NaN            None   \n",
       "56073                 <NA>             NaN            None   \n",
       "40602                 <NA>             NaN            None   \n",
       "38586                 <NA>             NaN            None   \n",
       "\n",
       "      references_citation references_pmid  \\\n",
       "8370                 None            None   \n",
       "13697                None            None   \n",
       "14814                None            None   \n",
       "20491                None            None   \n",
       "34504                None            None   \n",
       "...                   ...             ...   \n",
       "11632                None            None   \n",
       "25605                None            None   \n",
       "56073                None            None   \n",
       "40602                None            None   \n",
       "38586                None            None   \n",
       "\n",
       "                                      collaborators_name collaborators_class  \\\n",
       "8370   The Korean Academy of Tuberculosis and Respira...               OTHER   \n",
       "13697                                               None                None   \n",
       "14814                                               None                None   \n",
       "20491                                               None                None   \n",
       "34504                                               None                None   \n",
       "...                                                  ...                 ...   \n",
       "11632                                               None                None   \n",
       "25605                                               None                None   \n",
       "56073                         Zydus Lifesciences Limited            INDUSTRY   \n",
       "40602                                               None                None   \n",
       "38586                                               None                None   \n",
       "\n",
       "      ipd_sharing  success_prediction  economic_effect  duration_prediction  \\\n",
       "8370    UNDECIDED               0.910            0.500              896.000   \n",
       "13697          NO               0.890            0.480              895.000   \n",
       "14814        None               0.920            0.490             1373.000   \n",
       "20491          NO               0.900            0.500              219.000   \n",
       "34504         YES               0.880            0.460              115.000   \n",
       "...           ...                 ...              ...                  ...   \n",
       "11632          NO               0.860            0.420              234.000   \n",
       "25605        None               0.890            0.500              209.000   \n",
       "56073          NO               0.830            0.390             1053.000   \n",
       "40602          NO               0.920            0.500              137.000   \n",
       "38586          NO               0.920            0.500              115.000   \n",
       "\n",
       "       success_composite     class  \n",
       "8370               0.693  INDUSTRY  \n",
       "13697              0.674  INDUSTRY  \n",
       "14814              0.691  INDUSTRY  \n",
       "20491              0.714  INDUSTRY  \n",
       "34504              0.691  INDUSTRY  \n",
       "...                  ...       ...  \n",
       "11632              0.689  INDUSTRY  \n",
       "25605              0.754  INDUSTRY  \n",
       "56073              0.669  INDUSTRY  \n",
       "40602              0.728  INDUSTRY  \n",
       "38586              0.728  INDUSTRY  \n",
       "\n",
       "[57731 rows x 77 columns]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_apps"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th>source</th>\n",
       "      <th>subsidiary</th>\n",
       "      <th>sponsor</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>sponsor_study_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>lead_sponsor</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>lead_sponsor_type</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>study_type</th>\n",
       "      <th>enrollment_count</th>\n",
       "      <th>number_of_locations</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>study_size_category</th>\n",
       "      <th>condition_keywords</th>\n",
       "      <th>primary_condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>primary_intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_arm_group_labels</th>\n",
       "      <th>intervention_description</th>\n",
       "      <th>has_data_monitoring_committee</th>\n",
       "      <th>responsible_party_investigator_affiliation</th>\n",
       "      <th>responsible_party_investigator_title</th>\n",
       "      <th>responsible_party_investigator_name</th>\n",
       "      <th>first_posted_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_completion_date</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>study_locations_city</th>\n",
       "      <th>study_locations_country</th>\n",
       "      <th>study_locations_geopoint</th>\n",
       "      <th>study_locations_facility</th>\n",
       "      <th>study_locations_zip</th>\n",
       "      <th>study_locations_state</th>\n",
       "      <th>standard_age_groups</th>\n",
       "      <th>sex</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>status_category</th>\n",
       "      <th>status_verified_date</th>\n",
       "      <th>primary_outcomes_measures</th>\n",
       "      <th>primary_outcomes_timeframes</th>\n",
       "      <th>primary_outcomes_descriptions</th>\n",
       "      <th>secondary_outcomes_measures</th>\n",
       "      <th>secondary_outcomes_timeframes</th>\n",
       "      <th>secondary_outcomes_descriptions</th>\n",
       "      <th>has_results</th>\n",
       "      <th>conditions</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>masking</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>study_duration_days</th>\n",
       "      <th>trial_duration</th>\n",
       "      <th>references_type</th>\n",
       "      <th>references_citation</th>\n",
       "      <th>references_pmid</th>\n",
       "      <th>collaborators_name</th>\n",
       "      <th>collaborators_class</th>\n",
       "      <th>ipd_sharing</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "      <th>class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>AAPL</td>\n",
       "      <td>2018-02-02</td>\n",
       "      <td>listed</td>\n",
       "      <td>Apple  Inc.</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>NCT03426280</td>\n",
       "      <td>Activity Therapy After Kidney Transplant: A Pi...</td>\n",
       "      <td>44663</td>\n",
       "      <td>Activity Therapy After Kidney Transplant</td>\n",
       "      <td>Stanford University</td>\n",
       "      <td>Stanford University</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>13</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Kidney Transplant; Complications</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>Apple Watch Series 1</td>\n",
       "      <td>Apple Watch Series 1</td>\n",
       "      <td>Apple Watch</td>\n",
       "      <td>Clinic Pharmacists Will Issue Apple Watches To...</td>\n",
       "      <td>False</td>\n",
       "      <td>Stanford University</td>\n",
       "      <td>Clinical Assistant Professor</td>\n",
       "      <td>Xingxing Shelley Cheng</td>\n",
       "      <td>2018-02-08</td>\n",
       "      <td>2023-06-27</td>\n",
       "      <td>2018-05-01</td>\n",
       "      <td>2020-01-31</td>\n",
       "      <td>2020-01-31</td>\n",
       "      <td>Palo Alto</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 37.44188, lon: -122.14302</td>\n",
       "      <td>Stanford Hospital and Clinic</td>\n",
       "      <td>94304</td>\n",
       "      <td>California</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>stopped</td>\n",
       "      <td>2023-06-01</td>\n",
       "      <td>Activity Level (daily caloric consumption); % ...</td>\n",
       "      <td>1 year; 1st year of transplant</td>\n",
       "      <td>None</td>\n",
       "      <td>Weight; Hemoglobin A1c</td>\n",
       "      <td>1st year of transplant; 1st year of transplant</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Kidney Transplant; Complications</td>\n",
       "      <td>To Combat Post-Transplant Weight Gain, We Seek...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>640</td>\n",
       "      <td>640.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.110</td>\n",
       "      <td>0.050</td>\n",
       "      <td>640.000</td>\n",
       "      <td>0.069</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>AAPL</td>\n",
       "      <td>2018-02-27</td>\n",
       "      <td>listed</td>\n",
       "      <td>Apple  Inc.</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>NCT03492554</td>\n",
       "      <td>Electrocardiogram Clinical Validation Study</td>\n",
       "      <td>099-11774</td>\n",
       "      <td>Electrocardiogram Clinical Validation Study</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>602</td>\n",
       "      <td>5</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Large</td>\n",
       "      <td>nan</td>\n",
       "      <td>Atrial Fibrillation</td>\n",
       "      <td>OTHER; DEVICE</td>\n",
       "      <td>1-Lead ECG</td>\n",
       "      <td>1-Lead ECG; 12-Lead ECG</td>\n",
       "      <td>Atrial fibrillation (AF); Normal Sinus Rhythm ...</td>\n",
       "      <td>All Participants Will Record Three Single-Lead...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2018-04-10</td>\n",
       "      <td>2020-12-03</td>\n",
       "      <td>2018-03-12</td>\n",
       "      <td>2018-05-14</td>\n",
       "      <td>2018-05-14</td>\n",
       "      <td>Miami; Orlando; The Villages; Overland Park; S...</td>\n",
       "      <td>United States; United States; United States; U...</td>\n",
       "      <td>lat: 25.77427, lon: -80.19366; lat: 28.53834, ...</td>\n",
       "      <td>QPS; BioClinicia- Orlando; BioClinica- The Vil...</td>\n",
       "      <td>33143; 32806; 32162; 66211; 55102</td>\n",
       "      <td>Florida; Florida; Florida; Kansas; Minnesota</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>22</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2020-11-01</td>\n",
       "      <td>Number of Participants With Software's Rhythm ...</td>\n",
       "      <td>1 Day; 1 Day</td>\n",
       "      <td>Specificity of rhythm classification; Sensitiv...</td>\n",
       "      <td>Number of Participants With Software's Ability...</td>\n",
       "      <td>1 Day; 1 Day; 1 Day</td>\n",
       "      <td>Number of ECGs that pass a visual overlay; Dif...</td>\n",
       "      <td>True</td>\n",
       "      <td>Atrial Fibrillation</td>\n",
       "      <td>The Purpose Of The Study Is To Confirm The Sof...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>BASIC_SCIENCE</td>\n",
       "      <td>False</td>\n",
       "      <td>63</td>\n",
       "      <td>63.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Iqvia Pty Ltd</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.930</td>\n",
       "      <td>0.660</td>\n",
       "      <td>63.000</td>\n",
       "      <td>0.774</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>AAPL</td>\n",
       "      <td>2018-11-21</td>\n",
       "      <td>listed</td>\n",
       "      <td>Apple  Inc.</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>NCT03760796</td>\n",
       "      <td>The Johns Hopkins Myocardial Infarction, Combi...</td>\n",
       "      <td>IRB00099938</td>\n",
       "      <td>Myocardial Infarction, Combined-Device, Recove...</td>\n",
       "      <td>Johns Hopkins University</td>\n",
       "      <td>Johns Hopkins University</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>200</td>\n",
       "      <td>4</td>\n",
       "      <td>False</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Medium</td>\n",
       "      <td>readmission; cardiovascular disease prevention...</td>\n",
       "      <td>Acute Myocardial Infarction</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>Corrie Health Digital Platform</td>\n",
       "      <td>Corrie Health Digital Platform</td>\n",
       "      <td>Corrie Health Digital Platform group</td>\n",
       "      <td>The Corrie Health Digital Platform Consists Of...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2018-11-30</td>\n",
       "      <td>2021-07-29</td>\n",
       "      <td>2016-10-01</td>\n",
       "      <td>2019-12-17</td>\n",
       "      <td>2019-12-17</td>\n",
       "      <td>Baltimore; Baltimore; Boston; Reading</td>\n",
       "      <td>United States; United States; United States; U...</td>\n",
       "      <td>lat: 39.29038, lon: -76.61219; lat: 39.29038, ...</td>\n",
       "      <td>Johns Hopkins Bayview Medical Center; Johns Ho...</td>\n",
       "      <td>21224; 21287; 02114; 19611</td>\n",
       "      <td>Maryland; Maryland; Massachusetts; Pennsylvania</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>Number of Participants Readmitted Within 30-da...</td>\n",
       "      <td>30-days post hospital discharge</td>\n",
       "      <td>Number of participants readmitted within 30-da...</td>\n",
       "      <td>Cost-effectiveness as Assessed by a Markov Mod...</td>\n",
       "      <td>30 days post hospital discharge; 3 days post h...</td>\n",
       "      <td>We estimated typical costs associated with rea...</td>\n",
       "      <td>True</td>\n",
       "      <td>Acute Myocardial Infarction; Coronary Artery D...</td>\n",
       "      <td>Unplanned Readmissions After Hospitalization F...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>False</td>\n",
       "      <td>1172</td>\n",
       "      <td>1172.000</td>\n",
       "      <td>BACKGROUND; BACKGROUND; BACKGROUND; RESULT; RE...</td>\n",
       "      <td>Spaulding EM, Marvel FA, Lee MA, Yang WE, Demo...</td>\n",
       "      <td>31043065; 31094337; 31758761; 33999374; 329642...</td>\n",
       "      <td>Apple Inc.; iHealth</td>\n",
       "      <td>INDUSTRY; OTHER</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.560</td>\n",
       "      <td>1172.000</td>\n",
       "      <td>0.735</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>AAPL</td>\n",
       "      <td>2018-12-06</td>\n",
       "      <td>listed</td>\n",
       "      <td>Apple  Inc.</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>NCT03769207</td>\n",
       "      <td>Evaluation Of The Use Of Apple Watch Features ...</td>\n",
       "      <td>1.2</td>\n",
       "      <td>Evaluation Of The Use Of Apple Watch Features ...</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>17</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Atrial Fibrillation</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>Ambulatory ECG</td>\n",
       "      <td>Ambulatory ECG</td>\n",
       "      <td>Ambulatory ECG</td>\n",
       "      <td>Eligible Participants Are Asked To Wear The Am...</td>\n",
       "      <td>False</td>\n",
       "      <td>Stanford University</td>\n",
       "      <td>Assistant Professor of Medicine (Cardiovascula...</td>\n",
       "      <td>Marco Perez</td>\n",
       "      <td>2018-12-07</td>\n",
       "      <td>2020-10-20</td>\n",
       "      <td>2018-12-08</td>\n",
       "      <td>2019-08-20</td>\n",
       "      <td>2019-07-05</td>\n",
       "      <td>Stanford</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 37.42411, lon: -122.16608</td>\n",
       "      <td>Stanford University</td>\n",
       "      <td>94304</td>\n",
       "      <td>California</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>22</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>Atrial Fibrillation or Atrial Flutter (AF) of ...</td>\n",
       "      <td>During ambulatory ECG Monitoring (up to 8 days)</td>\n",
       "      <td>Detected on ambulatory ECG patch monitor for a...</td>\n",
       "      <td>Arrhythmias Other Than AF; Self-reported Conta...</td>\n",
       "      <td>During ambulatory ECG Monitoring (up to 8 days...</td>\n",
       "      <td>Detected on an ambulatory ECG patch monitor fo...</td>\n",
       "      <td>True</td>\n",
       "      <td>Atrial Fibrillation; Arrhythmias, Cardiac; Atr...</td>\n",
       "      <td>This Post-Marketing Study Is Conducted To Char...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>False</td>\n",
       "      <td>255</td>\n",
       "      <td>255.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.860</td>\n",
       "      <td>0.530</td>\n",
       "      <td>255.000</td>\n",
       "      <td>0.683</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>AAPL</td>\n",
       "      <td>2019-11-13</td>\n",
       "      <td>listed</td>\n",
       "      <td>Apple  Inc.</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>NCT04198194</td>\n",
       "      <td>Apple Heart &amp; Movement Study</td>\n",
       "      <td>2019P002257</td>\n",
       "      <td>Apple Heart &amp; Movement Study</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>Apple Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>500000</td>\n",
       "      <td>1</td>\n",
       "      <td>None</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>nan</td>\n",
       "      <td>Prevention</td>\n",
       "      <td>DIAGNOSTIC_TEST</td>\n",
       "      <td>Predictors of events</td>\n",
       "      <td>Predictors of events</td>\n",
       "      <td>Participants with events</td>\n",
       "      <td>Apple Heart \\&amp; Movement Study In Apple Researc...</td>\n",
       "      <td>True</td>\n",
       "      <td>Brigham and Women's Hospital</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Calum A. Macrae</td>\n",
       "      <td>2019-12-13</td>\n",
       "      <td>2021-07-23</td>\n",
       "      <td>NaT</td>\n",
       "      <td>2024-11-14</td>\n",
       "      <td>2024-11-14</td>\n",
       "      <td>Boston</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 42.35843, lon: -71.05977</td>\n",
       "      <td>Brigham and Women's Hospital</td>\n",
       "      <td>02115</td>\n",
       "      <td>Massachusetts</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>other</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>Number of Participants with Chronic Disease Ev...</td>\n",
       "      <td>quarterly (every 90 days) through study comple...</td>\n",
       "      <td>Change in number of participants with incident...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Prevention</td>\n",
       "      <td>This Study Will Look For Factors That Affect H...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>American Heart Association</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.280</td>\n",
       "      <td>0.050</td>\n",
       "      <td>618.000</td>\n",
       "      <td>0.169</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1477</th>\n",
       "      <td>PFE</td>\n",
       "      <td>2024-12-10</td>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06733337</td>\n",
       "      <td>Special Investigation Of Talzenna Capsules - S...</td>\n",
       "      <td>C3441050</td>\n",
       "      <td>A Study To Learn About The Safety Of Talzenna ...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>104</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>BRCA mutation-positive; metastatic castration-...</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-12-13</td>\n",
       "      <td>2024-12-13</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD; ADULT; OLDER_ADULT</td>\n",
       "      <td>MALE</td>\n",
       "      <td>0</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Incidence of adverse drug reactions</td>\n",
       "      <td>Up to 52 weeks</td>\n",
       "      <td>For adverse drug reactions corresponding to my...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>The Purpose Of This Study Is To Learn About Th...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.290</td>\n",
       "      <td>0.060</td>\n",
       "      <td>733.000</td>\n",
       "      <td>0.177</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1478</th>\n",
       "      <td>PFE</td>\n",
       "      <td>2024-12-11</td>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06735742</td>\n",
       "      <td>Talzenna Capsules Special Investigation - Inve...</td>\n",
       "      <td>C3441045</td>\n",
       "      <td>A Study To Learn About The Safety Of Talzenna ...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>37</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>BRCA mutation-positive and HER2-negative; unre...</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-12-16</td>\n",
       "      <td>2024-12-16</td>\n",
       "      <td>2025-01-31</td>\n",
       "      <td>2031-07-25</td>\n",
       "      <td>2031-07-25</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD; ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>0</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Incidence of adverse drug reactions</td>\n",
       "      <td>Up to 52 weeks</td>\n",
       "      <td>For adverse drug reactions corresponding to my...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>The Purpose Of This Study Is To Learn About Th...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>2366</td>\n",
       "      <td>2366.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.260</td>\n",
       "      <td>0.040</td>\n",
       "      <td>2417.000</td>\n",
       "      <td>0.139</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1479</th>\n",
       "      <td>PFE</td>\n",
       "      <td>2024-12-16</td>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06743334</td>\n",
       "      <td>Secondary Databased Post-Marketing Surveillanc...</td>\n",
       "      <td>C4591056</td>\n",
       "      <td>Secondary Databased Post-Marketing Surveillanc...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>10890000</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>COVID-19 Vaccines; Safety; SARS-CoV-2</td>\n",
       "      <td>Covid-19</td>\n",
       "      <td>BIOLOGICAL; BIOLOGICAL; BIOLOGICAL</td>\n",
       "      <td>Tozinameran (BNT162b2)</td>\n",
       "      <td>Tozinameran (BNT162b2); Tozinameran (BNT162b2)...</td>\n",
       "      <td>All primary series recipients using monovalent...</td>\n",
       "      <td>1. 12 Years Or Older\\n\\n   * Primary Series: 2...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2024-12-19</td>\n",
       "      <td>2024-12-19</td>\n",
       "      <td>2025-05-28</td>\n",
       "      <td>2025-05-28</td>\n",
       "      <td>2025-05-28</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>Pfizer Korea</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD; ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>0</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Frequency of Adverse Events of Special Interes...</td>\n",
       "      <td>Up to 270 days after vaccination; Up to 270 da...</td>\n",
       "      <td>Measure of Occurrence (Cohort design) The freq...</td>\n",
       "      <td>Frequency of Severe COVID-19 Outcomes; Inciden...</td>\n",
       "      <td>Up to 150 days after vaccination; Up to 150 da...</td>\n",
       "      <td>The frequency of severe COVID-19 outcomes incl...</td>\n",
       "      <td>False</td>\n",
       "      <td>Covid-19; Sars-Cov-2</td>\n",
       "      <td>This Study Is To Assess The Post-Marketing Saf...</td>\n",
       "      <td>This Study Is A Retrospective, Non-Interventio...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.280</td>\n",
       "      <td>0.050</td>\n",
       "      <td>163.000</td>\n",
       "      <td>0.177</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1480</th>\n",
       "      <td>PFE</td>\n",
       "      <td>2024-12-20</td>\n",
       "      <td>listed</td>\n",
       "      <td>Zydus Hospira Oncology Private Limited</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06757283</td>\n",
       "      <td>Evaluation Of Typhoid Conjugate Vaccine (Tcv) ...</td>\n",
       "      <td>PR-24059</td>\n",
       "      <td>Zyvac-Tcv Bangladesh Study</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>International Centre For Diarrhoeal Disease Re...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>4000</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Conjugate vaccine; Immunogenicity; Safety; Typ...</td>\n",
       "      <td>Typhoid Vaccination</td>\n",
       "      <td>BIOLOGICAL</td>\n",
       "      <td>Purified Vi capsular polysaccharide of Salmone...</td>\n",
       "      <td>Purified Vi capsular polysaccharide of Salmone...</td>\n",
       "      <td>Culture-negative control; Culture-positive case</td>\n",
       "      <td>Purified Vi Capsular Polysaccharide Of Salmone...</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-01-03</td>\n",
       "      <td>2025-01-03</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Dhaka</td>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>lat: 23.7104, lon: 90.40744</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>ALL</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Primary outcome</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Blood culture-confirmed typhoid fever</td>\n",
       "      <td>Secondary outcome; Secondary outcome</td>\n",
       "      <td>12 months; 12 months</td>\n",
       "      <td>Anti-Vi-IgG antibody concentration Blood cultu...</td>\n",
       "      <td>False</td>\n",
       "      <td>Typhoid Vaccination; Typhoid; Typhoid Fever</td>\n",
       "      <td>This Is A Prospective Closed Cohort, Open-Labe...</td>\n",
       "      <td>This Will Be A Phase Iii Effectiveness Study O...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.830</td>\n",
       "      <td>0.390</td>\n",
       "      <td>1053.000</td>\n",
       "      <td>0.669</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1481</th>\n",
       "      <td>PFE</td>\n",
       "      <td>2024-12-26</td>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06758401</td>\n",
       "      <td>An Open-Label, Randomized, Controlled Phase 3 ...</td>\n",
       "      <td>C5751003</td>\n",
       "      <td>This Is A Study To Learn About How The Combina...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>714</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Large</td>\n",
       "      <td>Lung Cancer; Carcinoma, Non-Small-Cell Lung; N...</td>\n",
       "      <td>Non-Small Cell Lung Cancer</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>Sigvotatug Vedotin</td>\n",
       "      <td>Sigvotatug Vedotin; Pembrolizumab</td>\n",
       "      <td>Arm A; Arm A; Arm B</td>\n",
       "      <td>Mmae-Antibody Drug Conjugate Targeting Integri...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-01-03</td>\n",
       "      <td>2025-01-03</td>\n",
       "      <td>2025-01-20</td>\n",
       "      <td>2029-02-17</td>\n",
       "      <td>2028-08-24</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-11-01</td>\n",
       "      <td>Overall Survival; Progression Free Survival (P...</td>\n",
       "      <td>Baseline to date of death from any cause (Appr...</td>\n",
       "      <td>Overall survival defined as the duration from ...</td>\n",
       "      <td>Progression Free Survival as assessed by Inves...</td>\n",
       "      <td>From Baseline to date of first progression or ...</td>\n",
       "      <td>Progression Free Survival (PFS) is defined as ...</td>\n",
       "      <td>False</td>\n",
       "      <td>Non-Small Cell Lung Cancer; Carcinoma, Non-Sma...</td>\n",
       "      <td>The Purpose Of The Study Is To Compare How The...</td>\n",
       "      <td>None</td>\n",
       "      <td>SINGLE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>1489</td>\n",
       "      <td>1489.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>YES</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.490</td>\n",
       "      <td>1514.000</td>\n",
       "      <td>0.753</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1482 rows × 77 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     ticker       date  source                              subsidiary  \\\n",
       "0      AAPL 2018-02-02  listed                             Apple  Inc.   \n",
       "1      AAPL 2018-02-27  listed                             Apple  Inc.   \n",
       "2      AAPL 2018-11-21  listed                             Apple  Inc.   \n",
       "3      AAPL 2018-12-06  listed                             Apple  Inc.   \n",
       "4      AAPL 2019-11-13  listed                             Apple  Inc.   \n",
       "...     ...        ...     ...                                     ...   \n",
       "1477    PFE 2024-12-10  listed                                  Pfizer   \n",
       "1478    PFE 2024-12-11  listed                                  Pfizer   \n",
       "1479    PFE 2024-12-16  listed                                  Pfizer   \n",
       "1480    PFE 2024-12-20  listed  Zydus Hospira Oncology Private Limited   \n",
       "1481    PFE 2024-12-26  listed                                  Pfizer   \n",
       "\n",
       "                         sponsor     trial_id  \\\n",
       "0                     Apple Inc.  NCT03426280   \n",
       "1                     Apple Inc.  NCT03492554   \n",
       "2                     Apple Inc.  NCT03760796   \n",
       "3                     Apple Inc.  NCT03769207   \n",
       "4                     Apple Inc.  NCT04198194   \n",
       "...                          ...          ...   \n",
       "1477                      Pfizer  NCT06733337   \n",
       "1478                      Pfizer  NCT06735742   \n",
       "1479                      Pfizer  NCT06743334   \n",
       "1480  Zydus Lifesciences Limited  NCT06757283   \n",
       "1481                      Pfizer  NCT06758401   \n",
       "\n",
       "                                         official_title sponsor_study_id  \\\n",
       "0     Activity Therapy After Kidney Transplant: A Pi...            44663   \n",
       "1           Electrocardiogram Clinical Validation Study        099-11774   \n",
       "2     The Johns Hopkins Myocardial Infarction, Combi...      IRB00099938   \n",
       "3     Evaluation Of The Use Of Apple Watch Features ...              1.2   \n",
       "4                          Apple Heart & Movement Study      2019P002257   \n",
       "...                                                 ...              ...   \n",
       "1477  Special Investigation Of Talzenna Capsules - S...         C3441050   \n",
       "1478  Talzenna Capsules Special Investigation - Inve...         C3441045   \n",
       "1479  Secondary Databased Post-Marketing Surveillanc...         C4591056   \n",
       "1480  Evaluation Of Typhoid Conjugate Vaccine (Tcv) ...         PR-24059   \n",
       "1481  An Open-Label, Randomized, Controlled Phase 3 ...         C5751003   \n",
       "\n",
       "                                            brief_title  \\\n",
       "0              Activity Therapy After Kidney Transplant   \n",
       "1           Electrocardiogram Clinical Validation Study   \n",
       "2     Myocardial Infarction, Combined-Device, Recove...   \n",
       "3     Evaluation Of The Use Of Apple Watch Features ...   \n",
       "4                          Apple Heart & Movement Study   \n",
       "...                                                 ...   \n",
       "1477  A Study To Learn About The Safety Of Talzenna ...   \n",
       "1478  A Study To Learn About The Safety Of Talzenna ...   \n",
       "1479  Secondary Databased Post-Marketing Surveillanc...   \n",
       "1480                         Zyvac-Tcv Bangladesh Study   \n",
       "1481  This Is A Study To Learn About How The Combina...   \n",
       "\n",
       "                                           lead_sponsor  \\\n",
       "0                                   Stanford University   \n",
       "1                                            Apple Inc.   \n",
       "2                              Johns Hopkins University   \n",
       "3                                            Apple Inc.   \n",
       "4                                            Apple Inc.   \n",
       "...                                                 ...   \n",
       "1477                                             Pfizer   \n",
       "1478                                             Pfizer   \n",
       "1479                                             Pfizer   \n",
       "1480  International Centre for Diarrhoeal Disease Re...   \n",
       "1481                                             Pfizer   \n",
       "\n",
       "                                      lead_sponsor_name sponsor_type  \\\n",
       "0                                   Stanford University        OTHER   \n",
       "1                                            Apple Inc.     INDUSTRY   \n",
       "2                              Johns Hopkins University        OTHER   \n",
       "3                                            Apple Inc.     INDUSTRY   \n",
       "4                                            Apple Inc.     INDUSTRY   \n",
       "...                                                 ...          ...   \n",
       "1477                                             Pfizer     INDUSTRY   \n",
       "1478                                             Pfizer     INDUSTRY   \n",
       "1479                                             Pfizer     INDUSTRY   \n",
       "1480  International Centre For Diarrhoeal Disease Re...        OTHER   \n",
       "1481                                             Pfizer     INDUSTRY   \n",
       "\n",
       "     lead_sponsor_type phase_category      study_type  enrollment_count  \\\n",
       "0                OTHER          other  INTERVENTIONAL                13   \n",
       "1             INDUSTRY          other  INTERVENTIONAL               602   \n",
       "2                OTHER          other  INTERVENTIONAL               200   \n",
       "3             INDUSTRY          other  INTERVENTIONAL                17   \n",
       "4             INDUSTRY  not_specified   OBSERVATIONAL            500000   \n",
       "...                ...            ...             ...               ...   \n",
       "1477          INDUSTRY  not_specified   OBSERVATIONAL               104   \n",
       "1478          INDUSTRY  not_specified   OBSERVATIONAL                37   \n",
       "1479          INDUSTRY  not_specified   OBSERVATIONAL          10890000   \n",
       "1480             OTHER        phase_3  INTERVENTIONAL              4000   \n",
       "1481          INDUSTRY        phase_3  INTERVENTIONAL               714   \n",
       "\n",
       "      number_of_locations healthy_volunteers enrollment_type  \\\n",
       "0                       1              False          ACTUAL   \n",
       "1                       5               True          ACTUAL   \n",
       "2                       4              False          ACTUAL   \n",
       "3                       1               True          ACTUAL   \n",
       "4                       1               None       ESTIMATED   \n",
       "...                   ...                ...             ...   \n",
       "1477                    0              False       ESTIMATED   \n",
       "1478                    0              False       ESTIMATED   \n",
       "1479                    1              False       ESTIMATED   \n",
       "1480                    1               True       ESTIMATED   \n",
       "1481                    0              False       ESTIMATED   \n",
       "\n",
       "     study_size_category                                 condition_keywords  \\\n",
       "0                  Small                                                nan   \n",
       "1                  Large                                                nan   \n",
       "2                 Medium  readmission; cardiovascular disease prevention...   \n",
       "3                  Small                                                nan   \n",
       "4             Very Large                                                nan   \n",
       "...                  ...                                                ...   \n",
       "1477              Medium  BRCA mutation-positive; metastatic castration-...   \n",
       "1478               Small  BRCA mutation-positive and HER2-negative; unre...   \n",
       "1479          Very Large              COVID-19 Vaccines; Safety; SARS-CoV-2   \n",
       "1480          Very Large  Conjugate vaccine; Immunogenicity; Safety; Typ...   \n",
       "1481               Large  Lung Cancer; Carcinoma, Non-Small-Cell Lung; N...   \n",
       "\n",
       "                     primary_condition                   intervention_type  \\\n",
       "0     Kidney Transplant; Complications                              DEVICE   \n",
       "1                  Atrial Fibrillation                       OTHER; DEVICE   \n",
       "2          Acute Myocardial Infarction                              DEVICE   \n",
       "3                  Atrial Fibrillation                              DEVICE   \n",
       "4                           Prevention                     DIAGNOSTIC_TEST   \n",
       "...                                ...                                 ...   \n",
       "1477                   Prostate Cancer                                 nan   \n",
       "1478                     Breast Cancer                                 nan   \n",
       "1479                          Covid-19  BIOLOGICAL; BIOLOGICAL; BIOLOGICAL   \n",
       "1480               Typhoid Vaccination                          BIOLOGICAL   \n",
       "1481        Non-Small Cell Lung Cancer                          DRUG; DRUG   \n",
       "\n",
       "                                   primary_intervention  \\\n",
       "0                                  Apple Watch Series 1   \n",
       "1                                            1-Lead ECG   \n",
       "2                        Corrie Health Digital Platform   \n",
       "3                                        Ambulatory ECG   \n",
       "4                                  Predictors of events   \n",
       "...                                                 ...   \n",
       "1477                                                nan   \n",
       "1478                                                nan   \n",
       "1479                             Tozinameran (BNT162b2)   \n",
       "1480  Purified Vi capsular polysaccharide of Salmone...   \n",
       "1481                                 Sigvotatug Vedotin   \n",
       "\n",
       "                                      intervention_name  \\\n",
       "0                                  Apple Watch Series 1   \n",
       "1                               1-Lead ECG; 12-Lead ECG   \n",
       "2                        Corrie Health Digital Platform   \n",
       "3                                        Ambulatory ECG   \n",
       "4                                  Predictors of events   \n",
       "...                                                 ...   \n",
       "1477                                                nan   \n",
       "1478                                                nan   \n",
       "1479  Tozinameran (BNT162b2); Tozinameran (BNT162b2)...   \n",
       "1480  Purified Vi capsular polysaccharide of Salmone...   \n",
       "1481                  Sigvotatug Vedotin; Pembrolizumab   \n",
       "\n",
       "                          intervention_arm_group_labels  \\\n",
       "0                                           Apple Watch   \n",
       "1     Atrial fibrillation (AF); Normal Sinus Rhythm ...   \n",
       "2                  Corrie Health Digital Platform group   \n",
       "3                                        Ambulatory ECG   \n",
       "4                              Participants with events   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479  All primary series recipients using monovalent...   \n",
       "1480    Culture-negative control; Culture-positive case   \n",
       "1481                                Arm A; Arm A; Arm B   \n",
       "\n",
       "                               intervention_description  \\\n",
       "0     Clinic Pharmacists Will Issue Apple Watches To...   \n",
       "1     All Participants Will Record Three Single-Lead...   \n",
       "2     The Corrie Health Digital Platform Consists Of...   \n",
       "3     Eligible Participants Are Asked To Wear The Am...   \n",
       "4     Apple Heart \\& Movement Study In Apple Researc...   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479  1. 12 Years Or Older\\n\\n   * Primary Series: 2...   \n",
       "1480  Purified Vi Capsular Polysaccharide Of Salmone...   \n",
       "1481  Mmae-Antibody Drug Conjugate Targeting Integri...   \n",
       "\n",
       "     has_data_monitoring_committee responsible_party_investigator_affiliation  \\\n",
       "0                            False                        Stanford University   \n",
       "1                            False                                       None   \n",
       "2                             None                                       None   \n",
       "3                            False                        Stanford University   \n",
       "4                             True               Brigham and Women's Hospital   \n",
       "...                            ...                                        ...   \n",
       "1477                          None                                       None   \n",
       "1478                          None                                       None   \n",
       "1479                         False                                       None   \n",
       "1480                          True                                       None   \n",
       "1481                          None                                       None   \n",
       "\n",
       "                   responsible_party_investigator_title  \\\n",
       "0                          Clinical Assistant Professor   \n",
       "1                                                  None   \n",
       "2                                                  None   \n",
       "3     Assistant Professor of Medicine (Cardiovascula...   \n",
       "4                                Principal Investigator   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479                                               None   \n",
       "1480                                               None   \n",
       "1481                                               None   \n",
       "\n",
       "     responsible_party_investigator_name first_posted_date  \\\n",
       "0                 Xingxing Shelley Cheng        2018-02-08   \n",
       "1                                   None        2018-04-10   \n",
       "2                                   None        2018-11-30   \n",
       "3                            Marco Perez        2018-12-07   \n",
       "4                        Calum A. Macrae        2019-12-13   \n",
       "...                                  ...               ...   \n",
       "1477                                None        2024-12-13   \n",
       "1478                                None        2024-12-16   \n",
       "1479                                None        2024-12-19   \n",
       "1480                                None        2025-01-03   \n",
       "1481                                None        2025-01-03   \n",
       "\n",
       "     last_update_posted_date start_date study_completion_date  \\\n",
       "0                 2023-06-27 2018-05-01            2020-01-31   \n",
       "1                 2020-12-03 2018-03-12            2018-05-14   \n",
       "2                 2021-07-29 2016-10-01            2019-12-17   \n",
       "3                 2020-10-20 2018-12-08            2019-08-20   \n",
       "4                 2021-07-23        NaT            2024-11-14   \n",
       "...                      ...        ...                   ...   \n",
       "1477              2024-12-13        NaT                   NaT   \n",
       "1478              2024-12-16 2025-01-31            2031-07-25   \n",
       "1479              2024-12-19 2025-05-28            2025-05-28   \n",
       "1480              2025-01-03        NaT                   NaT   \n",
       "1481              2025-01-03 2025-01-20            2029-02-17   \n",
       "\n",
       "     primary_completion_date  \\\n",
       "0                 2020-01-31   \n",
       "1                 2018-05-14   \n",
       "2                 2019-12-17   \n",
       "3                 2019-07-05   \n",
       "4                 2024-11-14   \n",
       "...                      ...   \n",
       "1477                     NaT   \n",
       "1478              2031-07-25   \n",
       "1479              2025-05-28   \n",
       "1480                     NaT   \n",
       "1481              2028-08-24   \n",
       "\n",
       "                                   study_locations_city  \\\n",
       "0                                             Palo Alto   \n",
       "1     Miami; Orlando; The Villages; Overland Park; S...   \n",
       "2                 Baltimore; Baltimore; Boston; Reading   \n",
       "3                                              Stanford   \n",
       "4                                                Boston   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479                                              Seoul   \n",
       "1480                                              Dhaka   \n",
       "1481                                               None   \n",
       "\n",
       "                                study_locations_country  \\\n",
       "0                                         United States   \n",
       "1     United States; United States; United States; U...   \n",
       "2     United States; United States; United States; U...   \n",
       "3                                         United States   \n",
       "4                                         United States   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479                                 Korea, Republic of   \n",
       "1480                                         Bangladesh   \n",
       "1481                                               None   \n",
       "\n",
       "                               study_locations_geopoint  \\\n",
       "0                        lat: 37.44188, lon: -122.14302   \n",
       "1     lat: 25.77427, lon: -80.19366; lat: 28.53834, ...   \n",
       "2     lat: 39.29038, lon: -76.61219; lat: 39.29038, ...   \n",
       "3                        lat: 37.42411, lon: -122.16608   \n",
       "4                         lat: 42.35843, lon: -71.05977   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479                         lat: 37.566, lon: 126.9784   \n",
       "1480                        lat: 23.7104, lon: 90.40744   \n",
       "1481                                               None   \n",
       "\n",
       "                               study_locations_facility  \\\n",
       "0                          Stanford Hospital and Clinic   \n",
       "1     QPS; BioClinicia- Orlando; BioClinica- The Vil...   \n",
       "2     Johns Hopkins Bayview Medical Center; Johns Ho...   \n",
       "3                                   Stanford University   \n",
       "4                          Brigham and Women's Hospital   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479                                       Pfizer Korea   \n",
       "1480  International Centre for Diarrhoeal Disease Re...   \n",
       "1481                                               None   \n",
       "\n",
       "                    study_locations_zip  \\\n",
       "0                                 94304   \n",
       "1     33143; 32806; 32162; 66211; 55102   \n",
       "2            21224; 21287; 02114; 19611   \n",
       "3                                 94304   \n",
       "4                                 02115   \n",
       "...                                 ...   \n",
       "1477                               None   \n",
       "1478                               None   \n",
       "1479                               None   \n",
       "1480                               None   \n",
       "1481                               None   \n",
       "\n",
       "                                study_locations_state  \\\n",
       "0                                          California   \n",
       "1        Florida; Florida; Florida; Kansas; Minnesota   \n",
       "2     Maryland; Maryland; Massachusetts; Pennsylvania   \n",
       "3                                          California   \n",
       "4                                       Massachusetts   \n",
       "...                                               ...   \n",
       "1477                                             None   \n",
       "1478                                             None   \n",
       "1479                                             None   \n",
       "1480                                             None   \n",
       "1481                                             None   \n",
       "\n",
       "            standard_age_groups   sex  minimum_age  maximum_age  \\\n",
       "0            ADULT; OLDER_ADULT   ALL           18         <NA>   \n",
       "1            ADULT; OLDER_ADULT   ALL           22         <NA>   \n",
       "2            ADULT; OLDER_ADULT   ALL           18         <NA>   \n",
       "3            ADULT; OLDER_ADULT   ALL           22         <NA>   \n",
       "4            ADULT; OLDER_ADULT   ALL           18         <NA>   \n",
       "...                         ...   ...          ...          ...   \n",
       "1477  CHILD; ADULT; OLDER_ADULT  MALE            0         <NA>   \n",
       "1478  CHILD; ADULT; OLDER_ADULT   ALL            0         <NA>   \n",
       "1479  CHILD; ADULT; OLDER_ADULT   ALL            0         <NA>   \n",
       "1480                      CHILD   ALL            0           15   \n",
       "1481         ADULT; OLDER_ADULT   ALL           18         <NA>   \n",
       "\n",
       "          overall_status status_category status_verified_date  \\\n",
       "0             TERMINATED         stopped           2023-06-01   \n",
       "1              COMPLETED       completed           2020-11-01   \n",
       "2              COMPLETED       completed           2021-07-01   \n",
       "3              COMPLETED       completed           2020-09-01   \n",
       "4                UNKNOWN           other           2021-07-01   \n",
       "...                  ...             ...                  ...   \n",
       "1477  NOT_YET_RECRUITING          active           2024-12-01   \n",
       "1478  NOT_YET_RECRUITING          active           2024-12-01   \n",
       "1479  NOT_YET_RECRUITING          active           2024-12-01   \n",
       "1480  NOT_YET_RECRUITING          active           2024-12-01   \n",
       "1481  NOT_YET_RECRUITING          active           2024-11-01   \n",
       "\n",
       "                              primary_outcomes_measures  \\\n",
       "0     Activity Level (daily caloric consumption); % ...   \n",
       "1     Number of Participants With Software's Rhythm ...   \n",
       "2     Number of Participants Readmitted Within 30-da...   \n",
       "3     Atrial Fibrillation or Atrial Flutter (AF) of ...   \n",
       "4     Number of Participants with Chronic Disease Ev...   \n",
       "...                                                 ...   \n",
       "1477                Incidence of adverse drug reactions   \n",
       "1478                Incidence of adverse drug reactions   \n",
       "1479  Frequency of Adverse Events of Special Interes...   \n",
       "1480                                    Primary outcome   \n",
       "1481  Overall Survival; Progression Free Survival (P...   \n",
       "\n",
       "                            primary_outcomes_timeframes  \\\n",
       "0                        1 year; 1st year of transplant   \n",
       "1                                          1 Day; 1 Day   \n",
       "2                       30-days post hospital discharge   \n",
       "3       During ambulatory ECG Monitoring (up to 8 days)   \n",
       "4     quarterly (every 90 days) through study comple...   \n",
       "...                                                 ...   \n",
       "1477                                     Up to 52 weeks   \n",
       "1478                                     Up to 52 weeks   \n",
       "1479  Up to 270 days after vaccination; Up to 270 da...   \n",
       "1480                                          12 months   \n",
       "1481  Baseline to date of death from any cause (Appr...   \n",
       "\n",
       "                          primary_outcomes_descriptions  \\\n",
       "0                                                  None   \n",
       "1     Specificity of rhythm classification; Sensitiv...   \n",
       "2     Number of participants readmitted within 30-da...   \n",
       "3     Detected on ambulatory ECG patch monitor for a...   \n",
       "4     Change in number of participants with incident...   \n",
       "...                                                 ...   \n",
       "1477  For adverse drug reactions corresponding to my...   \n",
       "1478  For adverse drug reactions corresponding to my...   \n",
       "1479  Measure of Occurrence (Cohort design) The freq...   \n",
       "1480              Blood culture-confirmed typhoid fever   \n",
       "1481  Overall survival defined as the duration from ...   \n",
       "\n",
       "                            secondary_outcomes_measures  \\\n",
       "0                                Weight; Hemoglobin A1c   \n",
       "1     Number of Participants With Software's Ability...   \n",
       "2     Cost-effectiveness as Assessed by a Markov Mod...   \n",
       "3     Arrhythmias Other Than AF; Self-reported Conta...   \n",
       "4                                                  None   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479  Frequency of Severe COVID-19 Outcomes; Inciden...   \n",
       "1480               Secondary outcome; Secondary outcome   \n",
       "1481  Progression Free Survival as assessed by Inves...   \n",
       "\n",
       "                          secondary_outcomes_timeframes  \\\n",
       "0        1st year of transplant; 1st year of transplant   \n",
       "1                                   1 Day; 1 Day; 1 Day   \n",
       "2     30 days post hospital discharge; 3 days post h...   \n",
       "3     During ambulatory ECG Monitoring (up to 8 days...   \n",
       "4                                                  None   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479  Up to 150 days after vaccination; Up to 150 da...   \n",
       "1480                               12 months; 12 months   \n",
       "1481  From Baseline to date of first progression or ...   \n",
       "\n",
       "                        secondary_outcomes_descriptions  has_results  \\\n",
       "0                                                  None        False   \n",
       "1     Number of ECGs that pass a visual overlay; Dif...         True   \n",
       "2     We estimated typical costs associated with rea...         True   \n",
       "3     Detected on an ambulatory ECG patch monitor fo...         True   \n",
       "4                                                  None        False   \n",
       "...                                                 ...          ...   \n",
       "1477                                               None        False   \n",
       "1478                                               None        False   \n",
       "1479  The frequency of severe COVID-19 outcomes incl...        False   \n",
       "1480  Anti-Vi-IgG antibody concentration Blood cultu...        False   \n",
       "1481  Progression Free Survival (PFS) is defined as ...        False   \n",
       "\n",
       "                                             conditions  \\\n",
       "0                      Kidney Transplant; Complications   \n",
       "1                                   Atrial Fibrillation   \n",
       "2     Acute Myocardial Infarction; Coronary Artery D...   \n",
       "3     Atrial Fibrillation; Arrhythmias, Cardiac; Atr...   \n",
       "4                                            Prevention   \n",
       "...                                                 ...   \n",
       "1477                                    Prostate Cancer   \n",
       "1478                                      Breast Cancer   \n",
       "1479                               Covid-19; Sars-Cov-2   \n",
       "1480        Typhoid Vaccination; Typhoid; Typhoid Fever   \n",
       "1481  Non-Small Cell Lung Cancer; Carcinoma, Non-Sma...   \n",
       "\n",
       "                                          brief_summary  \\\n",
       "0     To Combat Post-Transplant Weight Gain, We Seek...   \n",
       "1     The Purpose Of The Study Is To Confirm The Sof...   \n",
       "2     Unplanned Readmissions After Hospitalization F...   \n",
       "3     This Post-Marketing Study Is Conducted To Char...   \n",
       "4     This Study Will Look For Factors That Affect H...   \n",
       "...                                                 ...   \n",
       "1477  The Purpose Of This Study Is To Learn About Th...   \n",
       "1478  The Purpose Of This Study Is To Learn About Th...   \n",
       "1479  This Study Is To Assess The Post-Marketing Saf...   \n",
       "1480  This Is A Prospective Closed Cohort, Open-Labe...   \n",
       "1481  The Purpose Of The Study Is To Compare How The...   \n",
       "\n",
       "                                   detailed_description masking  \\\n",
       "0                                                  None    NONE   \n",
       "1                                                  None    NONE   \n",
       "2                                                  None    NONE   \n",
       "3                                                  None    NONE   \n",
       "4                                                  None    None   \n",
       "...                                                 ...     ...   \n",
       "1477                                               None    None   \n",
       "1478                                               None    None   \n",
       "1479  This Study Is A Retrospective, Non-Interventio...    None   \n",
       "1480  This Will Be A Phase Iii Effectiveness Study O...    NONE   \n",
       "1481                                               None  SINGLE   \n",
       "\n",
       "          allocation intervention_model primary_purpose  has_expanded_access  \\\n",
       "0     NON_RANDOMIZED           PARALLEL       TREATMENT                False   \n",
       "1     NON_RANDOMIZED           PARALLEL   BASIC_SCIENCE                False   \n",
       "2                 NA       SINGLE_GROUP      PREVENTION                False   \n",
       "3                 NA       SINGLE_GROUP           OTHER                False   \n",
       "4               None               None            None                False   \n",
       "...              ...                ...             ...                  ...   \n",
       "1477            None               None            None                False   \n",
       "1478            None               None            None                False   \n",
       "1479            None               None            None                False   \n",
       "1480  NON_RANDOMIZED       SINGLE_GROUP      PREVENTION                False   \n",
       "1481      RANDOMIZED           PARALLEL       TREATMENT                False   \n",
       "\n",
       "      study_duration_days  trial_duration  \\\n",
       "0                     640         640.000   \n",
       "1                      63          63.000   \n",
       "2                    1172        1172.000   \n",
       "3                     255         255.000   \n",
       "4                    <NA>             NaN   \n",
       "...                   ...             ...   \n",
       "1477                 <NA>             NaN   \n",
       "1478                 2366        2366.000   \n",
       "1479                    0           0.000   \n",
       "1480                 <NA>             NaN   \n",
       "1481                 1489        1489.000   \n",
       "\n",
       "                                        references_type  \\\n",
       "0                                                  None   \n",
       "1                                                  None   \n",
       "2     BACKGROUND; BACKGROUND; BACKGROUND; RESULT; RE...   \n",
       "3                                                  None   \n",
       "4                                                  None   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479                                               None   \n",
       "1480                                               None   \n",
       "1481                                               None   \n",
       "\n",
       "                                    references_citation  \\\n",
       "0                                                  None   \n",
       "1                                                  None   \n",
       "2     Spaulding EM, Marvel FA, Lee MA, Yang WE, Demo...   \n",
       "3                                                  None   \n",
       "4                                                  None   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479                                               None   \n",
       "1480                                               None   \n",
       "1481                                               None   \n",
       "\n",
       "                                        references_pmid  \\\n",
       "0                                                  None   \n",
       "1                                                  None   \n",
       "2     31043065; 31094337; 31758761; 33999374; 329642...   \n",
       "3                                                  None   \n",
       "4                                                  None   \n",
       "...                                                 ...   \n",
       "1477                                               None   \n",
       "1478                                               None   \n",
       "1479                                               None   \n",
       "1480                                               None   \n",
       "1481                                               None   \n",
       "\n",
       "              collaborators_name collaborators_class ipd_sharing  \\\n",
       "0                     Apple Inc.            INDUSTRY          NO   \n",
       "1                  Iqvia Pty Ltd            INDUSTRY          NO   \n",
       "2            Apple Inc.; iHealth     INDUSTRY; OTHER          NO   \n",
       "3                           None                None          NO   \n",
       "4     American Heart Association               OTHER          NO   \n",
       "...                          ...                 ...         ...   \n",
       "1477                        None                None          NO   \n",
       "1478                        None                None          NO   \n",
       "1479                        None                None          NO   \n",
       "1480  Zydus Lifesciences Limited            INDUSTRY          NO   \n",
       "1481                        None                None         YES   \n",
       "\n",
       "      success_prediction  economic_effect  duration_prediction  \\\n",
       "0                  0.110            0.050              640.000   \n",
       "1                  0.930            0.660               63.000   \n",
       "2                  0.950            0.560             1172.000   \n",
       "3                  0.860            0.530              255.000   \n",
       "4                  0.280            0.050              618.000   \n",
       "...                  ...              ...                  ...   \n",
       "1477               0.290            0.060              733.000   \n",
       "1478               0.260            0.040             2417.000   \n",
       "1479               0.280            0.050              163.000   \n",
       "1480               0.830            0.390             1053.000   \n",
       "1481               0.920            0.490             1514.000   \n",
       "\n",
       "      success_composite     class  \n",
       "0                 0.069  INDUSTRY  \n",
       "1                 0.774  INDUSTRY  \n",
       "2                 0.735  INDUSTRY  \n",
       "3                 0.683  INDUSTRY  \n",
       "4                 0.169  INDUSTRY  \n",
       "...                 ...       ...  \n",
       "1477              0.177  INDUSTRY  \n",
       "1478              0.139  INDUSTRY  \n",
       "1479              0.177  INDUSTRY  \n",
       "1480              0.669  INDUSTRY  \n",
       "1481              0.753  INDUSTRY  \n",
       "\n",
       "[1482 rows x 77 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_apps"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_clinical = sov.data(\"trials/predict\", full_history=True) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_clinical[\"links\"] = \"https://clinicaltrials.gov/study/\" + df_clinical[\"trial_id\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>date</th>\n",
       "      <th>ticker</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>official_title</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "      <th>links</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2010-08-12</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01181479</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>Open-Label, Randomized, Parallel Group, Study ...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.970</td>\n",
       "      <td>0.630</td>\n",
       "      <td>2882.000</td>\n",
       "      <td>0.841</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01181479</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2010-11-05</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01236768</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>An Open-Label, Randomized, Phase 3 Study Of Th...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.670</td>\n",
       "      <td>2506.000</td>\n",
       "      <td>0.846</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01236768</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2010-11-16</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01243580</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>An Open-Label Study To Evaluate Pharmacokineti...</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>0.960</td>\n",
       "      <td>0.630</td>\n",
       "      <td>2590.000</td>\n",
       "      <td>0.793</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01243580</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2010-11-29</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01250210</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>Evaluation Of Pharmacodynamic Effects On Ovula...</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.700</td>\n",
       "      <td>1084.000</td>\n",
       "      <td>0.850</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01250210</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2011-06-13</td>\n",
       "      <td>A</td>\n",
       "      <td>NCT01375946</td>\n",
       "      <td>Agile Therapeutics</td>\n",
       "      <td>A Pharmacokinetic And Wearability Study Of The...</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>0.940</td>\n",
       "      <td>0.630</td>\n",
       "      <td>2383.000</td>\n",
       "      <td>0.783</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01375946</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        date ticker     trial_id   lead_sponsor_name  \\\n",
       "0 2010-08-12      A  NCT01181479  Agile Therapeutics   \n",
       "1 2010-11-05      A  NCT01236768  Agile Therapeutics   \n",
       "2 2010-11-16      A  NCT01243580  Agile Therapeutics   \n",
       "3 2010-11-29      A  NCT01250210  Agile Therapeutics   \n",
       "4 2011-06-13      A  NCT01375946  Agile Therapeutics   \n",
       "\n",
       "                                      official_title phase_category  \\\n",
       "0  Open-Label, Randomized, Parallel Group, Study ...        phase_3   \n",
       "1  An Open-Label, Randomized, Phase 3 Study Of Th...        phase_3   \n",
       "2  An Open-Label Study To Evaluate Pharmacokineti...        phase_1   \n",
       "3  Evaluation Of Pharmacodynamic Effects On Ovula...        phase_2   \n",
       "4  A Pharmacokinetic And Wearability Study Of The...        phase_1   \n",
       "\n",
       "   success_prediction  economic_effect  duration_prediction  \\\n",
       "0               0.970            0.630             2882.000   \n",
       "1               0.950            0.670             2506.000   \n",
       "2               0.960            0.630             2590.000   \n",
       "3               0.950            0.700             1084.000   \n",
       "4               0.940            0.630             2383.000   \n",
       "\n",
       "   success_composite                                         links  \n",
       "0              0.841  https://clinicaltrials.gov/study/NCT01181479  \n",
       "1              0.846  https://clinicaltrials.gov/study/NCT01236768  \n",
       "2              0.793  https://clinicaltrials.gov/study/NCT01243580  \n",
       "3              0.850  https://clinicaltrials.gov/study/NCT01250210  \n",
       "4              0.783  https://clinicaltrials.gov/study/NCT01375946  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_clinical.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Trial Information"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_describe = sov.data(\"trials/describe\", full_history=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>sponsor_study_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>study_type</th>\n",
       "      <th>enrollment_count</th>\n",
       "      <th>number_of_locations</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>study_size_category</th>\n",
       "      <th>condition_keywords</th>\n",
       "      <th>primary_condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>primary_intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_arm_group_labels</th>\n",
       "      <th>intervention_description</th>\n",
       "      <th>has_data_monitoring_committee</th>\n",
       "      <th>responsible_party_investigator_affiliation</th>\n",
       "      <th>responsible_party_investigator_title</th>\n",
       "      <th>responsible_party_investigator_name</th>\n",
       "      <th>first_posted_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_completion_date</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>study_locations_city</th>\n",
       "      <th>study_locations_country</th>\n",
       "      <th>study_locations_geopoint</th>\n",
       "      <th>study_locations_facility</th>\n",
       "      <th>study_locations_zip</th>\n",
       "      <th>study_locations_state</th>\n",
       "      <th>standard_age_groups</th>\n",
       "      <th>sex</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>status_category</th>\n",
       "      <th>status_verified_date</th>\n",
       "      <th>primary_outcomes_measures</th>\n",
       "      <th>primary_outcomes_timeframes</th>\n",
       "      <th>primary_outcomes_descriptions</th>\n",
       "      <th>secondary_outcomes_measures</th>\n",
       "      <th>secondary_outcomes_timeframes</th>\n",
       "      <th>secondary_outcomes_descriptions</th>\n",
       "      <th>has_results</th>\n",
       "      <th>conditions</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>masking</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>study_duration_days</th>\n",
       "      <th>trial_duration</th>\n",
       "      <th>references_type</th>\n",
       "      <th>references_citation</th>\n",
       "      <th>references_pmid</th>\n",
       "      <th>collaborators_name</th>\n",
       "      <th>collaborators_class</th>\n",
       "      <th>ipd_sharing</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>513998</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2021-08-06</td>\n",
       "      <td>NCT05012462</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Aphe...</td>\n",
       "      <td>ZMS-1500-2021-Apheresis</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Aphe...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>75</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>None</td>\n",
       "      <td>The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2021-08-19</td>\n",
       "      <td>2022-12-21</td>\n",
       "      <td>2021-09-20</td>\n",
       "      <td>2022-12-20</td>\n",
       "      <td>2022-12-20</td>\n",
       "      <td>Denver</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847</td>\n",
       "      <td>Vitalant Blood Donation</td>\n",
       "      <td>80230</td>\n",
       "      <td>Colorado</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2022-12-01</td>\n",
       "      <td>Characterize changes in the Relative Index dur...</td>\n",
       "      <td>1-6 hours</td>\n",
       "      <td>The primary objective of the study is to chara...</td>\n",
       "      <td>Characterize changes in blood pressure relativ...</td>\n",
       "      <td>1-6 hours; 1-6 hours; 1-6 hours; 1-6 hours</td>\n",
       "      <td>Characterize changes in blood pressure that oc...</td>\n",
       "      <td>False</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>The Study Is A Prospective, Single-Arm, Non-Ra...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>456</td>\n",
       "      <td>456.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.080</td>\n",
       "      <td>456.000</td>\n",
       "      <td>0.211</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513999</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2021-11-08</td>\n",
       "      <td>NCT05125848</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Hemo...</td>\n",
       "      <td>ZMS-1500-2021-Dialysis</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Hemo...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>15</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>Hemodialysis Single Group Assignment</td>\n",
       "      <td>The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2021-11-18</td>\n",
       "      <td>2024-05-01</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Minneapolis</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 44.97997, lon: -93.26384</td>\n",
       "      <td>DaVita Clinical Research</td>\n",
       "      <td>55404</td>\n",
       "      <td>Minnesota</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-04-01</td>\n",
       "      <td>Average Relative Index Value Following a Hemod...</td>\n",
       "      <td>Duration of post-hemodialysis recovery period ...</td>\n",
       "      <td>The primary objective is to characterize the a...</td>\n",
       "      <td>Mean Intrasubject Variability (Standard Deviat...</td>\n",
       "      <td>Duration of standard dialysis procedure (Range...</td>\n",
       "      <td>The secondary objective is to characterize int...</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss; Dialysis</td>\n",
       "      <td>The Study Is A Prospective, Single-Arm, Non-Ra...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.560</td>\n",
       "      <td>0.290</td>\n",
       "      <td>905.000</td>\n",
       "      <td>0.443</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514000</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2022-07-14</td>\n",
       "      <td>NCT05463198</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>ZMS-1600-Blood Loss Detection</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>351</td>\n",
       "      <td>4</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>Blood Loss</td>\n",
       "      <td>Subjects Undergoing Blood Donation Will Be Con...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2022-07-18</td>\n",
       "      <td>2024-08-13</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>2023-05-26</td>\n",
       "      <td>2023-04-27</td>\n",
       "      <td>Denver; Bradenton; Columbus; Chattanooga</td>\n",
       "      <td>United States; United States; United States; U...</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847; lat: 27.49893, ...</td>\n",
       "      <td>Vitalant Research Institute; SunCoast Blood Ce...</td>\n",
       "      <td>80230; 34211; 31904; 37403</td>\n",
       "      <td>Colorado; Florida; Georgia; Tennessee</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-07-01</td>\n",
       "      <td>Change in the Relative Index (RI) After Minor ...</td>\n",
       "      <td>Recovery period following donation (10 minutes)</td>\n",
       "      <td>The objective of this study is to determine if...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>The Study Is A Prospective, Non-Randomized, No...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>254</td>\n",
       "      <td>254.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.520</td>\n",
       "      <td>254.000</td>\n",
       "      <td>0.732</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514001</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NCT05740644</td>\n",
       "      <td>Clinical Evaluation Of The Zynex Monitoring Sy...</td>\n",
       "      <td>PR 2022-516</td>\n",
       "      <td>Clinical Evaluation Of The Zynex Monitoring Sy...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>20</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>Blood Loss and Saline Infusion</td>\n",
       "      <td>Healthy Subjects Undergoing A Manual Blood Los...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2023-02-23</td>\n",
       "      <td>2024-07-16</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Louisville</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 39.97776, lon: -105.13193</td>\n",
       "      <td>Clinimark</td>\n",
       "      <td>80027</td>\n",
       "      <td>Colorado</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-06-01</td>\n",
       "      <td>CM-1600 Ability to Detect Minor Blood Loss; CM...</td>\n",
       "      <td>Duration of Recovery Period following blood dr...</td>\n",
       "      <td>The objective of this study is to determine if...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>This Is A Prospective, Single-Arm, Non-Randomi...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.460</td>\n",
       "      <td>0.180</td>\n",
       "      <td>519.000</td>\n",
       "      <td>0.353</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514002</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2023-07-26</td>\n",
       "      <td>NCT05980013</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>ZMS-1500-Pa2023</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>120</td>\n",
       "      <td>2</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE; DEVICE</td>\n",
       "      <td>Whole blood donation supine</td>\n",
       "      <td>Whole blood donation supine; Whole blood donat...</td>\n",
       "      <td>Supine Donation Position; Reclined Donation Po...</td>\n",
       "      <td>Subjects Will Undergo A 1-Unit Whole Blood Don...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2023-08-07</td>\n",
       "      <td>2024-05-16</td>\n",
       "      <td>2023-08-28</td>\n",
       "      <td>NaT</td>\n",
       "      <td>2024-04-10</td>\n",
       "      <td>Denver; Bradenton</td>\n",
       "      <td>United States; United States</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847; lat: 27.49893, ...</td>\n",
       "      <td>Vitalant Research Institute; SunCoast Blood Ce...</td>\n",
       "      <td>80230; 34211</td>\n",
       "      <td>Colorado; Florida</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-05-01</td>\n",
       "      <td>Impact of subject positioning on percent chang...</td>\n",
       "      <td>At completion of blood draw</td>\n",
       "      <td>Percent change in heart rate, forearm skin tem...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Fluid Loss; Blood Loss</td>\n",
       "      <td>The Study Is A Prospective, Non-Randomized, No...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.260</td>\n",
       "      <td>0.050</td>\n",
       "      <td>226.000</td>\n",
       "      <td>0.199</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ticker       date     trial_id  \\\n",
       "513998   ZYXI 2021-08-06  NCT05012462   \n",
       "513999   ZYXI 2021-11-08  NCT05125848   \n",
       "514000   ZYXI 2022-07-14  NCT05463198   \n",
       "514001   ZYXI 2023-02-13  NCT05740644   \n",
       "514002   ZYXI 2023-07-26  NCT05980013   \n",
       "\n",
       "                                           official_title  \\\n",
       "513998  Clinical Evaluation Of The Cm-1500 During Aphe...   \n",
       "513999  Clinical Evaluation Of The Cm-1500 During Hemo...   \n",
       "514000  Evaluation Of Physiological Variables And Dete...   \n",
       "514001  Clinical Evaluation Of The Zynex Monitoring Sy...   \n",
       "514002  Evaluation Of Physiological Variables And Dete...   \n",
       "\n",
       "                     sponsor_study_id  \\\n",
       "513998        ZMS-1500-2021-Apheresis   \n",
       "513999         ZMS-1500-2021-Dialysis   \n",
       "514000  ZMS-1600-Blood Loss Detection   \n",
       "514001                    PR 2022-516   \n",
       "514002                ZMS-1500-Pa2023   \n",
       "\n",
       "                                              brief_title  \\\n",
       "513998  Clinical Evaluation Of The Cm-1500 During Aphe...   \n",
       "513999  Clinical Evaluation Of The Cm-1500 During Hemo...   \n",
       "514000  Evaluation Of Physiological Variables And Dete...   \n",
       "514001  Clinical Evaluation Of The Zynex Monitoring Sy...   \n",
       "514002  Evaluation Of Physiological Variables And Dete...   \n",
       "\n",
       "                 lead_sponsor_name sponsor_type phase_category  \\\n",
       "513998  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "513999  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514000  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514001  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514002  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "\n",
       "            study_type  enrollment_count  number_of_locations  \\\n",
       "513998  INTERVENTIONAL                75                    1   \n",
       "513999  INTERVENTIONAL                15                    1   \n",
       "514000  INTERVENTIONAL               351                    4   \n",
       "514001  INTERVENTIONAL                20                    1   \n",
       "514002  INTERVENTIONAL               120                    2   \n",
       "\n",
       "       healthy_volunteers enrollment_type study_size_category  \\\n",
       "513998               True          ACTUAL               Small   \n",
       "513999              False          ACTUAL               Small   \n",
       "514000               True          ACTUAL              Medium   \n",
       "514001               True          ACTUAL               Small   \n",
       "514002               True          ACTUAL              Medium   \n",
       "\n",
       "       condition_keywords primary_condition intervention_type  \\\n",
       "513998                nan        Fluid Loss            DEVICE   \n",
       "513999                nan        Fluid Loss            DEVICE   \n",
       "514000                nan        Fluid Loss            DEVICE   \n",
       "514001                nan        Fluid Loss            DEVICE   \n",
       "514002                nan        Fluid Loss    DEVICE; DEVICE   \n",
       "\n",
       "               primary_intervention  \\\n",
       "513998                      CM-1500   \n",
       "513999                      CM-1500   \n",
       "514000                      CM-1600   \n",
       "514001                      CM-1600   \n",
       "514002  Whole blood donation supine   \n",
       "\n",
       "                                        intervention_name  \\\n",
       "513998                                            CM-1500   \n",
       "513999                                            CM-1500   \n",
       "514000                                            CM-1600   \n",
       "514001                                            CM-1600   \n",
       "514002  Whole blood donation supine; Whole blood donat...   \n",
       "\n",
       "                            intervention_arm_group_labels  \\\n",
       "513998                                               None   \n",
       "513999               Hemodialysis Single Group Assignment   \n",
       "514000                                         Blood Loss   \n",
       "514001                     Blood Loss and Saline Infusion   \n",
       "514002  Supine Donation Position; Reclined Donation Po...   \n",
       "\n",
       "                                 intervention_description  \\\n",
       "513998  The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...   \n",
       "513999  The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...   \n",
       "514000  Subjects Undergoing Blood Donation Will Be Con...   \n",
       "514001  Healthy Subjects Undergoing A Manual Blood Los...   \n",
       "514002  Subjects Will Undergo A 1-Unit Whole Blood Don...   \n",
       "\n",
       "       has_data_monitoring_committee  \\\n",
       "513998                         False   \n",
       "513999                         False   \n",
       "514000                         False   \n",
       "514001                         False   \n",
       "514002                         False   \n",
       "\n",
       "       responsible_party_investigator_affiliation  \\\n",
       "513998                                       None   \n",
       "513999                                       None   \n",
       "514000                                       None   \n",
       "514001                                       None   \n",
       "514002                                       None   \n",
       "\n",
       "       responsible_party_investigator_title  \\\n",
       "513998                                 None   \n",
       "513999                                 None   \n",
       "514000                                 None   \n",
       "514001                                 None   \n",
       "514002                                 None   \n",
       "\n",
       "       responsible_party_investigator_name first_posted_date  \\\n",
       "513998                                None        2021-08-19   \n",
       "513999                                None        2021-11-18   \n",
       "514000                                None        2022-07-18   \n",
       "514001                                None        2023-02-23   \n",
       "514002                                None        2023-08-07   \n",
       "\n",
       "       last_update_posted_date start_date study_completion_date  \\\n",
       "513998              2022-12-21 2021-09-20            2022-12-20   \n",
       "513999              2024-05-01        NaT                   NaT   \n",
       "514000              2024-08-13 2022-09-14            2023-05-26   \n",
       "514001              2024-07-16        NaT                   NaT   \n",
       "514002              2024-05-16 2023-08-28                   NaT   \n",
       "\n",
       "       primary_completion_date                      study_locations_city  \\\n",
       "513998              2022-12-20                                    Denver   \n",
       "513999                     NaT                               Minneapolis   \n",
       "514000              2023-04-27  Denver; Bradenton; Columbus; Chattanooga   \n",
       "514001                     NaT                                Louisville   \n",
       "514002              2024-04-10                         Denver; Bradenton   \n",
       "\n",
       "                                  study_locations_country  \\\n",
       "513998                                      United States   \n",
       "513999                                      United States   \n",
       "514000  United States; United States; United States; U...   \n",
       "514001                                      United States   \n",
       "514002                       United States; United States   \n",
       "\n",
       "                                 study_locations_geopoint  \\\n",
       "513998                      lat: 39.73915, lon: -104.9847   \n",
       "513999                      lat: 44.97997, lon: -93.26384   \n",
       "514000  lat: 39.73915, lon: -104.9847; lat: 27.49893, ...   \n",
       "514001                     lat: 39.97776, lon: -105.13193   \n",
       "514002  lat: 39.73915, lon: -104.9847; lat: 27.49893, ...   \n",
       "\n",
       "                                 study_locations_facility  \\\n",
       "513998                            Vitalant Blood Donation   \n",
       "513999                           DaVita Clinical Research   \n",
       "514000  Vitalant Research Institute; SunCoast Blood Ce...   \n",
       "514001                                          Clinimark   \n",
       "514002  Vitalant Research Institute; SunCoast Blood Ce...   \n",
       "\n",
       "               study_locations_zip                  study_locations_state  \\\n",
       "513998                       80230                               Colorado   \n",
       "513999                       55404                              Minnesota   \n",
       "514000  80230; 34211; 31904; 37403  Colorado; Florida; Georgia; Tennessee   \n",
       "514001                       80027                               Colorado   \n",
       "514002                80230; 34211                      Colorado; Florida   \n",
       "\n",
       "       standard_age_groups  sex  minimum_age  maximum_age overall_status  \\\n",
       "513998  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "513999  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514000  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514001  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514002  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "\n",
       "       status_category status_verified_date  \\\n",
       "513998       completed           2022-12-01   \n",
       "513999       completed           2024-04-01   \n",
       "514000       completed           2024-07-01   \n",
       "514001       completed           2024-06-01   \n",
       "514002       completed           2024-05-01   \n",
       "\n",
       "                                primary_outcomes_measures  \\\n",
       "513998  Characterize changes in the Relative Index dur...   \n",
       "513999  Average Relative Index Value Following a Hemod...   \n",
       "514000  Change in the Relative Index (RI) After Minor ...   \n",
       "514001  CM-1600 Ability to Detect Minor Blood Loss; CM...   \n",
       "514002  Impact of subject positioning on percent chang...   \n",
       "\n",
       "                              primary_outcomes_timeframes  \\\n",
       "513998                                          1-6 hours   \n",
       "513999  Duration of post-hemodialysis recovery period ...   \n",
       "514000    Recovery period following donation (10 minutes)   \n",
       "514001  Duration of Recovery Period following blood dr...   \n",
       "514002                        At completion of blood draw   \n",
       "\n",
       "                            primary_outcomes_descriptions  \\\n",
       "513998  The primary objective of the study is to chara...   \n",
       "513999  The primary objective is to characterize the a...   \n",
       "514000  The objective of this study is to determine if...   \n",
       "514001  The objective of this study is to determine if...   \n",
       "514002  Percent change in heart rate, forearm skin tem...   \n",
       "\n",
       "                              secondary_outcomes_measures  \\\n",
       "513998  Characterize changes in blood pressure relativ...   \n",
       "513999  Mean Intrasubject Variability (Standard Deviat...   \n",
       "514000                                               None   \n",
       "514001                                               None   \n",
       "514002                                               None   \n",
       "\n",
       "                            secondary_outcomes_timeframes  \\\n",
       "513998         1-6 hours; 1-6 hours; 1-6 hours; 1-6 hours   \n",
       "513999  Duration of standard dialysis procedure (Range...   \n",
       "514000                                               None   \n",
       "514001                                               None   \n",
       "514002                                               None   \n",
       "\n",
       "                          secondary_outcomes_descriptions  has_results  \\\n",
       "513998  Characterize changes in blood pressure that oc...        False   \n",
       "513999  The secondary objective is to characterize int...         True   \n",
       "514000                                               None         True   \n",
       "514001                                               None         True   \n",
       "514002                                               None        False   \n",
       "\n",
       "                    conditions  \\\n",
       "513998              Fluid Loss   \n",
       "513999    Fluid Loss; Dialysis   \n",
       "514000              Fluid Loss   \n",
       "514001              Fluid Loss   \n",
       "514002  Fluid Loss; Blood Loss   \n",
       "\n",
       "                                            brief_summary  \\\n",
       "513998  The Study Is A Prospective, Single-Arm, Non-Ra...   \n",
       "513999  The Study Is A Prospective, Single-Arm, Non-Ra...   \n",
       "514000  The Study Is A Prospective, Non-Randomized, No...   \n",
       "514001  This Is A Prospective, Single-Arm, Non-Randomi...   \n",
       "514002  The Study Is A Prospective, Non-Randomized, No...   \n",
       "\n",
       "       detailed_description masking      allocation intervention_model  \\\n",
       "513998                 None    NONE              NA       SINGLE_GROUP   \n",
       "513999                 None    NONE              NA       SINGLE_GROUP   \n",
       "514000                 None    NONE              NA       SINGLE_GROUP   \n",
       "514001                 None    NONE              NA       SINGLE_GROUP   \n",
       "514002                 None    NONE  NON_RANDOMIZED           PARALLEL   \n",
       "\n",
       "       primary_purpose  has_expanded_access  study_duration_days  \\\n",
       "513998      DIAGNOSTIC                False                  456   \n",
       "513999      DIAGNOSTIC                False                 <NA>   \n",
       "514000      DIAGNOSTIC                False                  254   \n",
       "514001      DIAGNOSTIC                False                 <NA>   \n",
       "514002      DIAGNOSTIC                False                 <NA>   \n",
       "\n",
       "        trial_duration references_type references_citation references_pmid  \\\n",
       "513998         456.000            None                None            None   \n",
       "513999             NaN            None                None            None   \n",
       "514000         254.000            None                None            None   \n",
       "514001             NaN            None                None            None   \n",
       "514002             NaN            None                None            None   \n",
       "\n",
       "       collaborators_name collaborators_class ipd_sharing  success_prediction  \\\n",
       "513998               None                None          NO               0.270   \n",
       "513999               None                None        None               0.560   \n",
       "514000               None                None          NO               0.910   \n",
       "514001               None                None          NO               0.460   \n",
       "514002               None                None          NO               0.260   \n",
       "\n",
       "        economic_effect  duration_prediction  success_composite  \n",
       "513998            0.080              456.000              0.211  \n",
       "513999            0.290              905.000              0.443  \n",
       "514000            0.520              254.000              0.732  \n",
       "514001            0.180              519.000              0.353  \n",
       "514002            0.050              226.000              0.199  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_describe.tail()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Specific Tickers Select"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_pfizer = sov.data(\"trials/predict\", tickers=[\"PFE\"]) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>date</th>\n",
       "      <th>ticker</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>official_title</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>513354</th>\n",
       "      <td>1999-10-18</td>\n",
       "      <td>WINT</td>\n",
       "      <td>NCT00004500</td>\n",
       "      <td>Windtree Therapeutics</td>\n",
       "      <td>A Multicenter, Randomized, Controlled Trial Co...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.060</td>\n",
       "      <td>0.490</td>\n",
       "      <td>1841.000</td>\n",
       "      <td>0.279</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512527</th>\n",
       "      <td>1999-10-18</td>\n",
       "      <td>UTHR</td>\n",
       "      <td>NCT00004497</td>\n",
       "      <td>United Therapeutics</td>\n",
       "      <td>None</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.600</td>\n",
       "      <td>5637.000</td>\n",
       "      <td>0.805</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32118</th>\n",
       "      <td>1999-10-29</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT00000174</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>None</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.490</td>\n",
       "      <td>2065.000</td>\n",
       "      <td>0.770</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36726</th>\n",
       "      <td>1999-11-01</td>\n",
       "      <td>PFE</td>\n",
       "      <td>NCT00003343</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>A Randomized, Double-Blind, Placebo-Controlled...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.300</td>\n",
       "      <td>0.170</td>\n",
       "      <td>4664.000</td>\n",
       "      <td>0.290</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36723</th>\n",
       "      <td>1999-11-01</td>\n",
       "      <td>PFE</td>\n",
       "      <td>NCT00003720</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>A Multicenter, Dose Escalating Study In Patien...</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.600</td>\n",
       "      <td>4679.000</td>\n",
       "      <td>0.742</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20808</th>\n",
       "      <td>2024-10-25</td>\n",
       "      <td>GSK</td>\n",
       "      <td>NCT06663436</td>\n",
       "      <td>Glaxosmithkline</td>\n",
       "      <td>A Phase 2 Single-Blind, Randomized, Controlled...</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>0.840</td>\n",
       "      <td>0.430</td>\n",
       "      <td>327.000</td>\n",
       "      <td>0.704</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32829</th>\n",
       "      <td>2024-10-27</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT06662812</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>Disease Characteristics And Treatment Patterns...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.070</td>\n",
       "      <td>730.000</td>\n",
       "      <td>0.204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32830</th>\n",
       "      <td>2024-10-27</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT06662825</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>Seg-2022-01 Patient Characteristics And Treatm...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.310</td>\n",
       "      <td>0.070</td>\n",
       "      <td>323.000</td>\n",
       "      <td>0.233</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>511796</th>\n",
       "      <td>2024-10-28</td>\n",
       "      <td>TEVA</td>\n",
       "      <td>NCT06664619</td>\n",
       "      <td>Teva Branded Pharmaceutical Products R&amp;D, Inc.</td>\n",
       "      <td>A 4-Week, Double-Blind, Placebo-Controlled, Pa...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.850</td>\n",
       "      <td>0.440</td>\n",
       "      <td>560.000</td>\n",
       "      <td>0.727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513423</th>\n",
       "      <td>2024-10-28</td>\n",
       "      <td>XBIT</td>\n",
       "      <td>NCT06664502</td>\n",
       "      <td>Eyebiotech Ltd.</td>\n",
       "      <td>A Phase 1/2A 2-Part Study Consisting Of An Ope...</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>0.870</td>\n",
       "      <td>0.470</td>\n",
       "      <td>550.000</td>\n",
       "      <td>0.731</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>48998 rows × 10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             date ticker     trial_id  \\\n",
       "513354 1999-10-18   WINT  NCT00004500   \n",
       "512527 1999-10-18   UTHR  NCT00004497   \n",
       "32118  1999-10-29    NVS  NCT00000174   \n",
       "36726  1999-11-01    PFE  NCT00003343   \n",
       "36723  1999-11-01    PFE  NCT00003720   \n",
       "...           ...    ...          ...   \n",
       "20808  2024-10-25    GSK  NCT06663436   \n",
       "32829  2024-10-27    NVS  NCT06662812   \n",
       "32830  2024-10-27    NVS  NCT06662825   \n",
       "511796 2024-10-28   TEVA  NCT06664619   \n",
       "513423 2024-10-28   XBIT  NCT06664502   \n",
       "\n",
       "                                     lead_sponsor_name  \\\n",
       "513354                           Windtree Therapeutics   \n",
       "512527                             United Therapeutics   \n",
       "32118                                         Novartis   \n",
       "36726                                           Pfizer   \n",
       "36723                                           Pfizer   \n",
       "...                                                ...   \n",
       "20808                                  Glaxosmithkline   \n",
       "32829                                         Novartis   \n",
       "32830                                         Novartis   \n",
       "511796  Teva Branded Pharmaceutical Products R&D, Inc.   \n",
       "513423                                 Eyebiotech Ltd.   \n",
       "\n",
       "                                           official_title phase_category  \\\n",
       "513354  A Multicenter, Randomized, Controlled Trial Co...        phase_3   \n",
       "512527                                               None        phase_3   \n",
       "32118                                                None        phase_3   \n",
       "36726   A Randomized, Double-Blind, Placebo-Controlled...        phase_3   \n",
       "36723   A Multicenter, Dose Escalating Study In Patien...        phase_1   \n",
       "...                                                   ...            ...   \n",
       "20808   A Phase 2 Single-Blind, Randomized, Controlled...        phase_2   \n",
       "32829   Disease Characteristics And Treatment Patterns...  not_specified   \n",
       "32830   Seg-2022-01 Patient Characteristics And Treatm...  not_specified   \n",
       "511796  A 4-Week, Double-Blind, Placebo-Controlled, Pa...        phase_3   \n",
       "513423  A Phase 1/2A 2-Part Study Consisting Of An Ope...        phase_2   \n",
       "\n",
       "        success_prediction  economic_effect  duration_prediction  \\\n",
       "513354               0.060            0.490             1841.000   \n",
       "512527               0.950            0.600             5637.000   \n",
       "32118                0.920            0.490             2065.000   \n",
       "36726                0.300            0.170             4664.000   \n",
       "36723                0.910            0.600             4679.000   \n",
       "...                    ...              ...                  ...   \n",
       "20808                0.840            0.430              327.000   \n",
       "32829                0.270            0.070              730.000   \n",
       "32830                0.310            0.070              323.000   \n",
       "511796               0.850            0.440              560.000   \n",
       "513423               0.870            0.470              550.000   \n",
       "\n",
       "        success_composite  \n",
       "513354              0.279  \n",
       "512527              0.805  \n",
       "32118               0.770  \n",
       "36726               0.290  \n",
       "36723               0.742  \n",
       "...                   ...  \n",
       "20808               0.704  \n",
       "32829               0.204  \n",
       "32830               0.233  \n",
       "511796              0.727  \n",
       "513423              0.731  \n",
       "\n",
       "[48998 rows x 10 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_clinical.sort_values(\"date\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#https://clinicaltrials.gov/study/NCT06628310"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.10"
  },
  "vscode": {
   "interpreter": {
    "hash": "b7bc88ef2312de8ccb6fe32ee45ed1b303064bae6342b11333199520ddc77aae"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
